<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">mBio</journal-id><journal-id journal-id-type="iso-abbrev">MBio</journal-id><journal-id journal-id-type="hwp">mbio</journal-id><journal-id journal-id-type="pmc">mbio</journal-id><journal-id journal-id-type="publisher-id">mBio</journal-id><journal-title-group><journal-title>mBio</journal-title></journal-title-group><issn pub-type="epub">2150-7511</issn><publisher><publisher-name>American Society of Microbiology</publisher-name><publisher-loc>1752 N St., N.W., Washington, DC</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">24449754</article-id><article-id pub-id-type="pmc">3903288</article-id><article-id pub-id-type="publisher-id">mBio01060-13</article-id><article-id pub-id-type="doi">10.1128/mBio.01060-13</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Analysis of the mRNA Targetome of MicroRNAs Expressed by Marek&#x02019;s Disease Virus</article-title><alt-title>Targetome of MDV-Encoded miRNAs</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Parnas</surname><given-names>Oren</given-names></name><xref ref-type="aff" rid="aff1"><sup>a</sup></xref></contrib><contrib contrib-type="author"><name><surname>Corcoran</surname><given-names>David L.</given-names></name><xref ref-type="aff" rid="aff2"><sup>b</sup></xref></contrib><contrib contrib-type="author"><name><surname>Cullen</surname><given-names>Bryan R.</given-names></name><xref ref-type="aff" rid="aff1"><sup>a</sup></xref></contrib><aff id="aff1"><label><sup>a</sup></label>Department of Molecular Genetics &#x00026; Microbiology and Center for Virology, Duke University Medical Center, Durham, North Carolina, USA</aff><aff id="aff2"><label><sup>b</sup></label>Institute for Genome Sciences and Policy, Duke University, Durham, North Carolina, USA</aff></contrib-group><author-notes><corresp id="cor1">Address correspondence to Bryan R. Cullen, <email>bryan.cullen@duke.edu</email>.</corresp><fn fn-type="edited-by"><p><bold>Editor</bold> Stephen Goff, Columbia University</p></fn></author-notes><pub-date pub-type="epub"><day>21</day><month>1</month><year>2014</year></pub-date><pub-date pub-type="collection"><season>Jan-Feb</season><year>2014</year></pub-date><volume>5</volume><issue>1</issue><elocation-id>e01060-13</elocation-id><history><date date-type="received"><day>11</day><month>12</month><year>2013</year></date><date date-type="accepted"><day>16</day><month>12</month><year>2013</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2014 Parnas et al.</copyright-statement><copyright-year>2014</copyright-year><copyright-holder>Parnas et al.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0/"><license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0/">Creative Commons Attribution-Noncommercial-ShareAlike 3.0 Unported license</ext-link>, which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><abstract><title>ABSTRACT</title><p>Marek&#x02019;s disease virus 1 (MDV-1), an oncogenic &#x003b1;-herpesvirus that induces T-cell lymphomas in chickens, serves as model system to study transformation by lymphotropic herpesviruses. Like the oncogenic human &#x003b3;-herpesviruses Kaposi&#x02019;s sarcoma-associated herpesvirus (KSHV) and Epstein-Barr virus (EBV), MDV-1 encodes several viral microRNAs (miRNAs). One MDV-1 miRNA, miR-M4, shares the same &#x0201c;seed&#x0201d; targeting sequence with both a KSHV miRNA, miR-K11, and cellular miR-155. Importantly, miR-M4 plays a critical role in T-cell transformation by MDV-1, while miR-K11 and cellular miR-155 are thought to play key roles in B-cell transformation by KSHV and EBV, respectively. Here, we present an analysis of the mRNAs targeted by viral miRNAs expressed in the chicken T-cell line MSB1, which is naturally coinfected with MDV-1 and the related nonpathogenic virus MDV-2. Our analysis identified &#x0003e;1,000 endogenous mRNAs targeted by miRNAs encoded by each virus, many of which are targeted by both MDV-1 and MDV-2 miRNAs. We present a functional analysis of an MDV-1 gene, RLORF8, targeted by four MDV-1 miRNAs and a cellular gene, encoding interleukin-18 (IL-18) and targeted by both MDV-1 and MDV-2 miRNAs, and show that ectopic expression of either protein in a form resistant to miRNA inhibition results in inhibition of cell proliferation. Finally, we present a restricted list of 9 genes targeted by not only MDV-1 miR-M4 but also KSHV miR-K11 and human miR-155. Given the critical role played by miR-155 seed family members in lymphomagenesis in humans and chickens, these mRNA targets may contain genes whose inhibition plays a conserved role in herpesvirus transformation.</p></abstract><abstract abstract-type="executive-summary"><title>IMPORTANCE</title><p>Herpesviruses cause lymphomas in both humans and chickens, and in both cases, evidence indicates that virally encoded miRNAs, or virally subverted cellular miRNAs, belonging to the miR-155 seed family, play a critical role in this process. However, because each miRNA regulates numerous cellular mRNAs species, it has been difficult to elucidate which miRNA targets are important. Given the evolutionary distance between chickens and humans and the observation that miR-155 is nevertheless highly conserved in both species, we reasoned that the identification of shared miR-155 targets might shed light on this process. Here, we present an analysis of the mRNAs targeted by miRNAs encoded by the oncogenic avian herpesvirus MDV-1 in transformed chicken T cells, including a short list of mRNAs that are also targeted by miR-155 seed family miRNAs in EBV- or KSHV-transformed human B cells, and present an initial functional analysis of some of these miRNA targets.</p></abstract><counts><page-count count="12"/></counts><custom-meta-group><custom-meta><meta-name>cover-date</meta-name><meta-value>January/February 2014</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="h0.0"><title>INTRODUCTION</title><p> MicroRNAs (miRNAs) are small, ~22-nucleotide (nt) regulatory RNAs that can downregulate the expression of mRNAs bearing complementary target sequences (<xref rid="B1" ref-type="bibr">1</xref>). miRNAs are initially transcribed in the nucleus as long primary miRNA (pri-miRNA) precursors that contain one or several miRNAs embedded in the stems of imperfect, ~80-nt-long stem-loop structures. These stem-loops are targets for the nuclear RNase III enzyme Drosha, which cleaves the stem ~22&#x000a0;bp from the terminal loop to liberate an ~60-nt hairpin RNA called a pre-miRNA intermediate (<xref rid="B2" ref-type="bibr">2</xref>). After export to the cytoplasm (<xref rid="B3" ref-type="bibr">3</xref>), the pre-miRNA is cleaved by a second RNase III enzyme, Dicer, to liberate the ~22-bp miRNA duplex intermediate (<xref rid="B4" ref-type="bibr">4</xref>). One strand of this duplex then associates with a cellular Argonaute (Ago) protein to generate the RNA-induced silencing complex RISC (<xref rid="B1" ref-type="bibr">1</xref>). While one strand of the miRNA duplex intermediate is generally strongly favored for incorporation into RISC, with the other strand being degraded, this discrimination is rarely complete, and potentially significant levels of the other strand, referred to as the miRNA passenger or star strand, can often be detected (<xref rid="B5" ref-type="bibr">5</xref>). Once incorporated into RISC, the miRNA acts as a guide RNA to target RISC to mRNAs bearing partially or fully complementary target sites, resulting in their translation inhibition and/or degradation (<xref rid="B1" ref-type="bibr">1</xref>). Functional miRNA target sites are generally located in the mRNA 3&#x02032; untranslated region (UTR), and while miRNA homology to the target site does not need to be extensive, full complementarity to nucleotides 2 to 7 or 8 of the miRNA, referred to as the miRNA seed region, is generally required for effective downregulation (<xref rid="B1" ref-type="bibr">1</xref>).</p><p>Analysis of the potential of viruses to express miRNAs has shown that almost all herpesviruses of humans and animals encode multiple viral miRNAs that play a role in downregulating cellular mRNAs, often encoding factors with antiviral potential, as well as in some cases regulating the expression of viral mRNAs, including mRNAs encoding factors involved in the latent-to-lytic transition of viral infections (<xref rid="B6" ref-type="bibr">6</xref><xref ref-type="bibr" rid="B7">&#x02013;</xref><xref rid="B9" ref-type="bibr">9</xref>). Chickens are subject to infection by two members of the <italic>Mardivirus</italic> genus of avian &#x003b1;-herpesviruses, Marek&#x02019;s disease virus type 1 (MDV&#x02011;1) and MDV-2 (<xref rid="B10" ref-type="bibr">10</xref>). MDV-1 causes an economically important poultry disease (<xref rid="B11" ref-type="bibr">11</xref>) and induces rapid-onset T-cell lymphomas within weeks of infection of susceptible chickens (<xref rid="B12" ref-type="bibr">12</xref>). In contrast, the related virus MDV-2 is nonpathogenic and is widely used as a vaccine to prevent disease caused by MDV-1. MDV-1 and MDV-2 have previously been reported to encode 13 and 18 distinct pre-miRNAs, respectively, that give rise to numerous miRNAs and miRNA passenger strands, with some of the latter being expressed at substantial levels (<xref rid="B13" ref-type="bibr">13</xref><xref ref-type="bibr" rid="B14">&#x02013;</xref><xref rid="B18" ref-type="bibr">18</xref>). However, little is known about the mRNAs targeted by these viral miRNAs, although some mRNAs are encoded antisense to viral coding sequences and therefore clearly have the potential to restrict the expression of specific viral proteins (<xref rid="B18" ref-type="bibr">18</xref>). One MDV&#x02011;1 miRNA that has drawn significant attention is miR-M4, as it has the same seed sequence as both the cellular miRNA miR-155 (<xref rid="B17" ref-type="bibr">17</xref>, <xref rid="B19" ref-type="bibr">19</xref>), conserved in both humans and chickens, and another viral miRNA, miR-K11, expressed by the oncogenic human &#x003b3;-herpesvirus Kaposi&#x02019;s sarcoma-associated virus (KSHV) (<xref rid="B20" ref-type="bibr">20</xref>, <xref rid="B21" ref-type="bibr">21</xref>). Importantly, previous work has clearly demonstrated that KSHV miR-K11 and human miR-155 can indeed target very similar populations of cellular mRNAs (<xref rid="B20" ref-type="bibr">20</xref>, <xref rid="B21" ref-type="bibr">21</xref>) and that miR-K11 can even substitute for miR-155 in promoting the normal development of B cells <italic>in vivo</italic> (<xref rid="B22" ref-type="bibr">22</xref>, <xref rid="B23" ref-type="bibr">23</xref>).</p><p>While miR-155 is required for normal function of lymphoid cells, inappropriate expression is associated with B- and T-cell lymphoma development (<xref rid="B24" ref-type="bibr">24</xref>). Moreover, while for technical reasons it remains unclear whether miR-K11 promotes oncogenesis by KSHV, it is known that B-cell transformation by Epstein-Barr virus (EBV), a second oncogenic human &#x003b3;-herpesvirus, requires the massive transcriptional upregulation of cellular miR-155 expression (<xref rid="B25" ref-type="bibr">25</xref>, <xref rid="B26" ref-type="bibr">26</xref>), presumably to compensate for the fact that EBV, unlike KSHV, does not encode a miR-155 analog. Finally, analysis of miR-M4 function has shown that MDV-1 mutants lacking miR-M4 are severely attenuated in their ability to induce T-cell lymphomas in chickens, even though viral replication <italic>per se</italic> was largely unaffected (<xref rid="B27" ref-type="bibr">27</xref>). Therefore, these data indicate that transformation of B cells by human &#x003b3;-herpesviruses, and transformation of T cells by MDV-1, requires the downregulation of one or more cellular mRNA species by a miR-155 seed family miRNA. As chicken and human miR-155 are essentially identical, we hypothesize that the same key cellular mRNAs are involved in transformation by EBV, KSHV, and MDV-1.</p><p>Previously, we sought to identify mRNA targets for KSHV miR-K11 and human miR&#x02011;155 by photoactivatable ribonucleoside-enhanced cross-linking and immunoprecipitation (PAR-CLIP) analysis of RISC binding sites in KSHV- or EBV-transformed human B-cell lines (<xref rid="B28" ref-type="bibr">28</xref>, <xref rid="B29" ref-type="bibr">29</xref>), and similar studies have also been performed in latently KSHV- or EBV-infected B cells using the similar HITS-CLIP (high-throughput sequencing of RNA isolated by CLIP) technology (<xref rid="B30" ref-type="bibr">30</xref>, <xref rid="B31" ref-type="bibr">31</xref>). PAR-CLIP and HITS-CLIP are techniques that allow the recovery of RISC binding sites by inducing cross-linking of mRNAs to bound RISC by UV irradiation followed by recovery, reverse transcription, and deep sequencing of these RNA binding sites (<xref rid="B28" ref-type="bibr">28</xref><xref ref-type="bibr" rid="B29">&#x02013;</xref><xref rid="B33" ref-type="bibr">33</xref>). The millions of reads obtained are then bioinformatically analyzed (<xref rid="B34" ref-type="bibr">34</xref>), to identify RISC binding clusters on mRNAs and to assign the miRNA that has guided RISC to that cluster. Using this approach, we were previously able to identify ~500 mRNAs targeted by miR-155 and ~410 mRNAs targeted by miR-K11 (<xref rid="B28" ref-type="bibr">28</xref>, <xref rid="B29" ref-type="bibr">29</xref>), of which at least 231 were targeted by both miRNA species. However, this is still an unwieldy number. We therefore were interested in whether analysis of miR-M4 target sites in an MDV-1-infected chicken T-cell lymphoma would identify a smaller number of mRNAs that are targeted not only by miR-155 and miR-K11 in human cells but also by miR-M4 in chicken cells. As chicken mRNA 3&#x02032; UTRs are generally quite divergent from human mRNA 3&#x02032; UTRs, this seemed likely to be the case.</p><p>In this article, we present an analysis of the expression and mRNA targetome of MDV-1 and MDV-2 miRNAs present in the chicken T-cell lymphoma cell line MSB1 (<xref rid="B15" ref-type="bibr">15</xref>, <xref rid="B35" ref-type="bibr">35</xref>), which is naturally coinfected by MDV-1 and MDV-2. We did not identify any novel MDV-1 or MDV-2 pre-miRNAs but did confirm the existence of the previously reported 13 MDV-1 and 18 MDV-2 pre-miRNAs (<xref rid="B13" ref-type="bibr">13</xref><xref ref-type="bibr" rid="B14">&#x02013;</xref><xref rid="B18" ref-type="bibr">18</xref>). Interestingly, we demonstrate that three MDV-1 miRNAs and 4 MDV-2 miRNAs exist in two isoforms that differ by one or two nucleotides at their 5&#x02032; ends. This gives rise to two different seed sequences, and we demonstrate that each of these six viral miRNAs actually targets two overlapping but distinct sets of cellular mRNAs. Moreover, MDV-1 miR-M9-5p has the same seed sequence as the longer isoform of MDV&#x02011;2, miR-M28-5p, which represents the first demonstration that MDV-1 and MDV-2 miRNAs have the potential to target some of the same sites on mRNAs. Indeed, PAR-CLIP analysis of the 3&#x02032; UTRs of cellular mRNAs bound by MDV-1 and MDV&#x02011;2 miRNAs shows that these extensively overlap, albeit in most cases at distinct sites.</p><p>In terms of target identification, our data confirm that MDV-1 miR-M4, miR-M2, miR-M3, and miR-M12, located antisense to the viral RLORF8 gene, indeed restrict RLORF8 expression and demonstrate that ectopic RLORF8 expression, in a form resistant to miRNA inhibition, is toxic for MSB1 cells. We also identify the chicken interleukin-18 (IL-18) mRNA 3&#x02032; UTR as a target for two MDV-1 and five MDV-2 miRNAs and show that ectopic expression of IL-18 in a form lacking its 3&#x02032; UTR is also inhibitory for MSB1 cell growth. Finally, we identify a restricted set of nine mRNA 3&#x02032; UTRs targeted not only by miR-155 and miR-K11 in human B cells but also by miR-M4 in chicken T cells and demonstrate that these mRNAs are indeed susceptible to inhibition by both miR-155 and miR-M4. This will hopefully inform and facilitate our ongoing efforts to define the mRNA targets for miR-K11 and miR-155 that are important for lymphomagenesis in humans.</p></sec><sec sec-type="results" id="h1"><title>RESULTS</title><sec id="h1.1"><title>Analysis of the MDV-1 and MDV-2 microRNA expression profile.</title><p>Conventional and deep sequencing analyses of the viral miRNAs expressed by MDV-1 and MDV-2 have previously identified 13 pre-miRNAs encoded by MDV-1 and 18 pre-miRNAs encoded by MDV-2 (<xref rid="B13" ref-type="bibr">13</xref><xref ref-type="bibr" rid="B14">&#x02013;</xref><xref rid="B18" ref-type="bibr">18</xref>). While these miRNAs are derived from analogous regions of the viral genome, this work did not identify any MDV-1 and MDV-2 miRNAs with the same seed sequence and hence the potential to target a similar set of mRNA transcripts.</p><p>We performed deep sequencing of small, ~18- to 25-nt-long RNAs expressed in MSB1 cells, a chicken lymphoblastoid cell line previously shown to be naturally infected by both MDV-1 and MDV-2 (<xref rid="B14" ref-type="bibr">14</xref>, <xref rid="B15" ref-type="bibr">15</xref>). This generated 186,022,013 reads, of which 184,005,445 could be aligned to either the chicken genome or the MDV-1 or MDV-2 genome. Of these, 161,068,074 (88%) aligned to known chicken, MDV-1, or MDV-2 pre-miRNAs, as listed in miRBase version 19. Reads aligning to known chicken miRNAs contributed 49% of the total miRNAs detected, while MDV-1 and MDV-2 contributed 42% and 9%, respectively (<xref ref-type="fig" rid="fig1">Fig.&#x000a0;1A</xref>). The most highly expressed single miRNA, chicken miR-21, contributed ~22% of all miRNAs detected, followed by MDV-1 miR-M4 (10%), MDV-1 miR-M3 (10%), chicken miR-142 (7%), and MDV-1 miR-M1 (6%) (<xref ref-type="fig" rid="fig1">Fig.&#x000a0;1B</xref>). The most highly expressed MDV-2 miRNA, miR-M29, contributed 4% of all miRNA reads.</p><fig id="fig1" position="float"><label>FIG&#x000a0;1&#x000a0;</label><caption><p>Analysis of the small-RNA library generated from MSB1 cells. (A) Cellular and viral distribution of observed miRNAs. (B) The most abundant chicken, MDV-1, and MDV-2 miRNAs present in MSB1 cells are indicated. (C) Primer extension analysis of four viral miRNAs that show predicted 5'-end variation. This experiment was performed using total RNA from MSB1 cells. Total RNA from MDV-negative 293T cells was used as a control. (D) These MDV-1 and MDV-2 miRNAs share the same seed sequence.</p></caption><graphic xlink:href="mbo0011417180001"/></fig><p>Analysis of all small RNA reads that mapped to the MDV-1 or MDV-2 genome failed to identify any novel viral miRNAs and confirmed the expression of miRNAs and, in most cases, miRNA passenger strands derived from all of the 13 previously reported MDV-1 pre-miRNAs and 18 MDV-2 pre-miRNAs (<xref rid="B13" ref-type="bibr">13</xref><xref ref-type="bibr" rid="B14">&#x02013;</xref><xref rid="B18" ref-type="bibr">18</xref>). The major isoforms of the MDV miRNAs and miRNA passenger strands derived from these 31 pre-miRNA precursors are listed in <xref ref-type="table" rid="tab1 tab2">Tables&#x000a0;1 and 2</xref>. Given the key role played by the miRNA seed region (<xref rid="B1" ref-type="bibr">1</xref>), nucleotides 2 through 8, in mRNA target identification, we were not surprised to find that viral miRNA sequence variation was primarily restricted to the 3&#x02032; end, which plays a less important role in target selection. However, we did note several viral miRNAs that were processed into two different miRNA species that differed at their 5&#x02032; ends and therefore would be predicted to target overlapping but distinct mRNA populations. These included MDV-1 miR-M3-5p, where a 5&#x02032; end variant of the dominant miRNA provided 16% of all reads, as well as MDV-1 miR-M7-5p (38%), and miR-M12-3p (10%) (<xref ref-type="table" rid="tab1">Table&#x000a0;1</xref>). In MDV-2, major 5&#x02032; variants were detected for miR-14-5p (31%), miR-M18-5p (14%), miR-M24-3p (13%), and miR-M28-5p (29%) (<xref ref-type="table" rid="tab2">Table&#x000a0;2</xref>). To confirm that viral miRNAs are indeed expressed in two major isoforms that differ at their 5&#x02032; ends, we performed primer extension analysis for several of these viral miRNAs. These data confirmed the existence of two isoforms of MDV-1 miR-M3-5p and miR-M7-5p, as well as MDV-2 miR-M18-5p, that differ by 1&#x000a0;nt and two isoforms of MDV-2 miR-M28-5p that differ by 2&#x000a0;nt at their 5&#x02032; ends (<xref ref-type="fig" rid="fig1">Fig.&#x000a0;1C</xref>). Interestingly, the novel, extended isoform of MDV-2 miR-28-5p has the same predicted seed sequence as MDV-1 miR-M9-5p (<xref ref-type="fig" rid="fig1">Fig.&#x000a0;1D</xref>), and this therefore represents the first example of an MDV-1 and MDV-2 miRNA pair with the same seed sequence and hence, presumably, a similar mRNA target population.</p><table-wrap id="tab1" position="float"><label>TABLE&#x000a0;1&#x000a0;</label><caption><p>MDV-1 miRNAs expressed in MSB-1 cells<sup><xref rid="ngtab1.1"><italic>a</italic></xref></sup></p></caption><table frame="hsides" rules="groups"><thead valign="bottom"><tr><th align="left" rowspan="2" colspan="1">miRNA</th><th align="left" rowspan="2" colspan="1">Sequence</th><th align="left" rowspan="2" colspan="1">Length</th><th align="left" colspan="2" rowspan="1">Position<hr/></th><th align="left" rowspan="2" colspan="1">Frequency</th><th align="left" rowspan="2" colspan="1">%</th></tr><tr><th align="left" rowspan="1" colspan="1">Beginning</th><th align="left" rowspan="1" colspan="1">End</th></tr></thead><tbody valign="top"><tr><td align="left" style="shaded" rowspan="1" colspan="1">MDV1-M1-5p</td><td align="left" style="shaded" rowspan="1" colspan="1">TGCTTGTTCACTGTGCGGCATT</td><td align="left" style="shaded" rowspan="1" colspan="1">22</td><td align="left" style="shaded" rowspan="1" colspan="1">4725</td><td align="left" style="shaded" rowspan="1" colspan="1">4746</td><td align="left" style="shaded" rowspan="1" colspan="1">5,220,661</td><td align="left" style="shaded" rowspan="1" colspan="1">51</td></tr><tr><td align="left" style="shaded" rowspan="1" colspan="1"/><td align="left" style="shaded" rowspan="1" colspan="1">TGCTTGTTCACTGTGCGGCATTA</td><td align="left" style="shaded" rowspan="1" colspan="1">23</td><td align="left" style="shaded" rowspan="1" colspan="1">4724</td><td align="left" style="shaded" rowspan="1" colspan="1">4746</td><td align="left" style="shaded" rowspan="1" colspan="1">3,483,446</td><td align="left" style="shaded" rowspan="1" colspan="1">34</td></tr><tr><td align="left" rowspan="1" colspan="1">MDV1-M1-3p</td><td align="left" rowspan="1" colspan="1">ATGCTGCGCATGAAAGAGCGA</td><td align="left" rowspan="1" colspan="1">21</td><td align="left" rowspan="1" colspan="1">4687</td><td align="left" rowspan="1" colspan="1">4707</td><td align="left" rowspan="1" colspan="1">38,270</td><td align="left" rowspan="1" colspan="1">68</td></tr><tr><td align="left" rowspan="3" style="shaded" colspan="1">MDV1-M2-5p</td><td align="left" style="shaded" rowspan="1" colspan="1">GTTGTATTCTGCCCGGTAGTCCGT</td><td align="left" style="shaded" rowspan="1" colspan="1">24</td><td align="left" style="shaded" rowspan="1" colspan="1">7365</td><td align="left" style="shaded" rowspan="1" colspan="1">7388</td><td align="left" style="shaded" rowspan="1" colspan="1">773,504</td><td align="left" style="shaded" rowspan="1" colspan="1">43</td></tr><tr><td align="left" style="shaded" rowspan="1" colspan="1">GTTGTATTCTGCCCGGTAGTCCGTT</td><td align="left" style="shaded" rowspan="1" colspan="1">25</td><td align="left" style="shaded" rowspan="1" colspan="1">7364</td><td align="left" style="shaded" rowspan="1" colspan="1">7388</td><td align="left" style="shaded" rowspan="1" colspan="1">420,366</td><td align="left" style="shaded" rowspan="1" colspan="1">24</td></tr><tr><td align="left" style="shaded" rowspan="1" colspan="1">GTTGTATTCTGCCCGGTAGTCCG</td><td align="left" style="shaded" rowspan="1" colspan="1">23</td><td align="left" style="shaded" rowspan="1" colspan="1">7366</td><td align="left" style="shaded" rowspan="1" colspan="1">7388</td><td align="left" style="shaded" rowspan="1" colspan="1">291,031</td><td align="left" style="shaded" rowspan="1" colspan="1">16</td></tr><tr><td align="left" rowspan="1" colspan="1">MDV1-M2-3p</td><td align="left" rowspan="1" colspan="1">CGGACTGCCGCAGAATAGCTT</td><td align="left" rowspan="1" colspan="1">21</td><td align="left" rowspan="1" colspan="1">7328</td><td align="left" rowspan="1" colspan="1">7348</td><td align="left" rowspan="1" colspan="1">285,919</td><td align="left" rowspan="1" colspan="1">56</td></tr><tr><td align="left" rowspan="2" style="shaded" colspan="1">MDV1-M3-5p</td><td align="left" style="shaded" rowspan="1" colspan="1">ATGAAAATGTGAAACCTCTCCCGC</td><td align="left" style="shaded" rowspan="1" colspan="1">24</td><td align="left" style="shaded" rowspan="1" colspan="1">7516</td><td align="left" style="shaded" rowspan="1" colspan="1">7539</td><td align="left" style="shaded" rowspan="1" colspan="1">8,707,716</td><td align="left" style="shaded" rowspan="1" colspan="1">54</td></tr><tr><td align="left" style="shaded" rowspan="1" colspan="1">TGAAAATGTGAAACCTCTCCCGC</td><td align="left" style="shaded" rowspan="1" colspan="1">23</td><td align="left" style="shaded" rowspan="1" colspan="1">7516</td><td align="left" style="shaded" rowspan="1" colspan="1">7538</td><td align="left" style="shaded" rowspan="1" colspan="1">2,554,622</td><td align="left" style="shaded" rowspan="1" colspan="1">16</td></tr><tr><td align="left" rowspan="1" colspan="1">MDV1-M3-3p</td><td align="left" rowspan="1" colspan="1">TGGGGGGTTCACATTTTTAAGT</td><td align="left" rowspan="1" colspan="1">22</td><td align="left" rowspan="1" colspan="1">7479</td><td align="left" rowspan="1" colspan="1">7500</td><td align="left" rowspan="1" colspan="1">129</td><td align="left" rowspan="1" colspan="1">70</td></tr><tr><td align="left" rowspan="3" style="shaded" colspan="1">MDV1-M4-5p</td><td align="left" style="shaded" rowspan="1" colspan="1">TTAATGCTGTATCGGAACCCTTCGT</td><td align="left" style="shaded" rowspan="1" colspan="1">25</td><td align="left" style="shaded" rowspan="1" colspan="1">7227</td><td align="left" style="shaded" rowspan="1" colspan="1">7251</td><td align="left" style="shaded" rowspan="1" colspan="1">7,837,697</td><td align="left" style="shaded" rowspan="1" colspan="1">47</td></tr><tr><td align="left" style="shaded" rowspan="1" colspan="1">TTAATGCTGTATCGGAACCCTTCG</td><td align="left" style="shaded" rowspan="1" colspan="1">24</td><td align="left" style="shaded" rowspan="1" colspan="1">7228</td><td align="left" style="shaded" rowspan="1" colspan="1">7251</td><td align="left" style="shaded" rowspan="1" colspan="1">4,059,588</td><td align="left" style="shaded" rowspan="1" colspan="1">25</td></tr><tr><td align="left" style="shaded" rowspan="1" colspan="1">TTAATGCTGTATCGGAACCCTTC</td><td align="left" style="shaded" rowspan="1" colspan="1">23</td><td align="left" style="shaded" rowspan="1" colspan="1">7229</td><td align="left" style="shaded" rowspan="1" colspan="1">7251</td><td align="left" style="shaded" rowspan="1" colspan="1">2,754,899</td><td align="left" style="shaded" rowspan="1" colspan="1">17</td></tr><tr><td align="left" rowspan="1" colspan="1">MDV1-M4-3p</td><td align="left" rowspan="1" colspan="1">AATGGTTCTGACAGCATGACC</td><td align="left" rowspan="1" colspan="1">21</td><td align="left" rowspan="1" colspan="1">7194</td><td align="left" rowspan="1" colspan="1">7214</td><td align="left" rowspan="1" colspan="1">42,714</td><td align="left" rowspan="1" colspan="1">40</td></tr><tr><td align="left" style="shaded" rowspan="1" colspan="1">MDV1-M5-5p</td><td align="left" style="shaded" rowspan="1" colspan="1">CGTATGCGATCACATTGACACG</td><td align="left" style="shaded" rowspan="1" colspan="1">22</td><td align="left" style="shaded" rowspan="1" colspan="1">7990</td><td align="left" style="shaded" rowspan="1" colspan="1">8011</td><td align="left" style="shaded" rowspan="1" colspan="1">867</td><td align="left" style="shaded" rowspan="1" colspan="1">57</td></tr><tr><td align="left" rowspan="1" colspan="1">MDV1-M5-3p</td><td align="left" rowspan="1" colspan="1">TGTGTATCGTGGTCGTCTACTGT</td><td align="left" rowspan="1" colspan="1">23</td><td align="left" rowspan="1" colspan="1">7950</td><td align="left" rowspan="1" colspan="1">7972</td><td align="left" rowspan="1" colspan="1">1,069,623</td><td align="left" rowspan="1" colspan="1">84</td></tr><tr><td align="left" rowspan="2" style="shaded" colspan="1">MDV1-M6-5p</td><td align="left" style="shaded" rowspan="1" colspan="1">TGTTGTTCCGTAGTGTTCTCG</td><td align="left" style="shaded" rowspan="1" colspan="1">21</td><td align="left" style="shaded" rowspan="1" colspan="1">176086</td><td align="left" style="shaded" rowspan="1" colspan="1">176106</td><td align="left" style="shaded" rowspan="1" colspan="1">3,255,817</td><td align="left" style="shaded" rowspan="1" colspan="1">65</td></tr><tr><td align="left" style="shaded" rowspan="1" colspan="1">TGTTGTTCCGTAGTGTTCTCGT</td><td align="left" style="shaded" rowspan="1" colspan="1">22</td><td align="left" style="shaded" rowspan="1" colspan="1">176085</td><td align="left" style="shaded" rowspan="1" colspan="1">176106</td><td align="left" style="shaded" rowspan="1" colspan="1">1,045,694</td><td align="left" style="shaded" rowspan="1" colspan="1">21</td></tr><tr><td align="left" rowspan="1" colspan="1">MDV1-M6-3p</td><td align="left" rowspan="1" colspan="1">AGATCCCTGCGAAATGACAGT</td><td align="left" rowspan="1" colspan="1">21</td><td align="left" rowspan="1" colspan="1">176053</td><td align="left" rowspan="1" colspan="1">176073</td><td align="left" rowspan="1" colspan="1">76,487</td><td align="left" rowspan="1" colspan="1">77</td></tr><tr><td align="left" rowspan="3" style="shaded" colspan="1">MDV1-M7-5p</td><td align="left" style="shaded" rowspan="1" colspan="1">GTTATCTCGGGGAGATCTCGAT</td><td align="left" style="shaded" rowspan="1" colspan="1">22</td><td align="left" style="shaded" rowspan="1" colspan="1">175913</td><td align="left" style="shaded" rowspan="1" colspan="1">175934</td><td align="left" style="shaded" rowspan="1" colspan="1">1,527,552</td><td align="left" style="shaded" rowspan="1" colspan="1">39</td></tr><tr><td align="left" style="shaded" rowspan="1" colspan="1">TGTTATCTCGGGGAGATCTCGA</td><td align="left" style="shaded" rowspan="1" colspan="1">22</td><td align="left" style="shaded" rowspan="1" colspan="1">175914</td><td align="left" style="shaded" rowspan="1" colspan="1">175935</td><td align="left" style="shaded" rowspan="1" colspan="1">1,490,315</td><td align="left" style="shaded" rowspan="1" colspan="1">38</td></tr><tr><td align="left" style="shaded" rowspan="1" colspan="1">GTTATCTCGGGGAGATCTCGA</td><td align="left" style="shaded" rowspan="1" colspan="1">21</td><td align="left" style="shaded" rowspan="1" colspan="1">175914</td><td align="left" style="shaded" rowspan="1" colspan="1">175934</td><td align="left" style="shaded" rowspan="1" colspan="1">523,225</td><td align="left" style="shaded" rowspan="1" colspan="1">13</td></tr><tr><td align="left" rowspan="1" colspan="1">MDV1-M7-3p</td><td align="left" rowspan="1" colspan="1">GAGATCTCTACGAGATTACAGT</td><td align="left" rowspan="1" colspan="1">22</td><td align="left" rowspan="1" colspan="1">175874</td><td align="left" rowspan="1" colspan="1">175895</td><td align="left" rowspan="1" colspan="1">26,918</td><td align="left" rowspan="1" colspan="1">43</td></tr><tr><td align="left" style="shaded" rowspan="1" colspan="1">MDV1-M8-5p</td><td align="left" style="shaded" rowspan="1" colspan="1">TATTGTTCTGTGGTTGGTTTCGA</td><td align="left" style="shaded" rowspan="1" colspan="1">23</td><td align="left" style="shaded" rowspan="1" colspan="1">176205</td><td align="left" style="shaded" rowspan="1" colspan="1">176227</td><td align="left" style="shaded" rowspan="1" colspan="1">346,016</td><td align="left" style="shaded" rowspan="1" colspan="1">51</td></tr><tr><td align="left" rowspan="2" colspan="1">MDV1-M8-3p</td><td align="left" rowspan="1" colspan="1">TGACCTCTACGGAACAATAGT</td><td align="left" rowspan="1" colspan="1">21</td><td align="left" rowspan="1" colspan="1">176206</td><td align="left" rowspan="1" colspan="1">176227</td><td align="left" rowspan="1" colspan="1">803,339</td><td align="left" rowspan="1" colspan="1">71</td></tr><tr><td align="left" rowspan="1" colspan="1">TGACCTCTACGGAACAATAGC</td><td align="left" rowspan="1" colspan="1">21</td><td align="left" rowspan="1" colspan="1">176164</td><td align="left" rowspan="1" colspan="1">176184</td><td align="left" rowspan="1" colspan="1">126,023</td><td align="left" rowspan="1" colspan="1">11</td></tr><tr><td align="left" style="shaded" rowspan="1" colspan="1">MDV1-M9-5p</td><td align="left" style="shaded" rowspan="1" colspan="1">TTTTCTCCTTCCCCCCGGAGTTC</td><td align="left" style="shaded" rowspan="1" colspan="1">23</td><td align="left" style="shaded" rowspan="1" colspan="1">8223</td><td align="left" style="shaded" rowspan="1" colspan="1">8245</td><td align="left" style="shaded" rowspan="1" colspan="1">564,957</td><td align="left" style="shaded" rowspan="1" colspan="1">72</td></tr><tr><td align="left" rowspan="1" colspan="1">MDV1-M9-3p</td><td align="left" rowspan="1" colspan="1">AAACTCCGAGGGCAGGAAAAAG</td><td align="left" rowspan="1" colspan="1">22</td><td align="left" rowspan="1" colspan="1">8184</td><td align="left" rowspan="1" colspan="1">8205</td><td align="left" rowspan="1" colspan="1">13,504</td><td align="left" rowspan="1" colspan="1">51</td></tr><tr><td align="left" style="shaded" rowspan="1" colspan="1">MDV1-M10-5p</td><td align="left" style="shaded" rowspan="1" colspan="1">GCGTTGTCTCGTAGAGGTCCCGA</td><td align="left" style="shaded" rowspan="1" colspan="1">23</td><td align="left" style="shaded" rowspan="1" colspan="1">175795</td><td align="left" style="shaded" rowspan="1" colspan="1">175817</td><td align="left" style="shaded" rowspan="1" colspan="1">11,127</td><td align="left" style="shaded" rowspan="1" colspan="1">51</td></tr><tr><td align="left" rowspan="1" colspan="1">MDV1-M10-3p</td><td align="left" rowspan="1" colspan="1">GAAATCTCTACGAGATAACAGT</td><td align="left" rowspan="1" colspan="1">22</td><td align="left" rowspan="1" colspan="1">175753</td><td align="left" rowspan="1" colspan="1">175774</td><td align="left" rowspan="1" colspan="1">1,290,839</td><td align="left" rowspan="1" colspan="1">86</td></tr><tr><td align="left" rowspan="2" style="shaded" colspan="1">MDV1-M11-5p</td><td align="left" style="shaded" rowspan="1" colspan="1">TTTTCCTTACCGTGTAGCTTAGA</td><td align="left" style="shaded" rowspan="1" colspan="1">23</td><td align="left" style="shaded" rowspan="1" colspan="1">5544</td><td align="left" style="shaded" rowspan="1" colspan="1">5566</td><td align="left" style="shaded" rowspan="1" colspan="1">16,899</td><td align="left" style="shaded" rowspan="1" colspan="1">80</td></tr><tr><td align="left" style="shaded" rowspan="1" colspan="1">TTTTCCTTACCGTGTAGCTTAG</td><td align="left" style="shaded" rowspan="1" colspan="1">22</td><td align="left" style="shaded" rowspan="1" colspan="1">5545</td><td align="left" style="shaded" rowspan="1" colspan="1">5566</td><td align="left" style="shaded" rowspan="1" colspan="1">2,499</td><td align="left" style="shaded" rowspan="1" colspan="1">12</td></tr><tr><td align="left" rowspan="1" colspan="1">MDV1-M11-3p</td><td align="left" rowspan="1" colspan="1">TGAGTTACATGGTCAGGGGATT</td><td align="left" rowspan="1" colspan="1">22</td><td align="left" rowspan="1" colspan="1">5506</td><td align="left" rowspan="1" colspan="1">5527</td><td align="left" rowspan="1" colspan="1">264</td><td align="left" rowspan="1" colspan="1">77</td></tr><tr><td align="left" style="shaded" rowspan="1" colspan="1">MDV1-M12-5p</td><td align="left" style="shaded" rowspan="1" colspan="1">AGGCCCTCCGTATAATGTAAAT</td><td align="left" style="shaded" rowspan="1" colspan="1">22</td><td align="left" style="shaded" rowspan="1" colspan="1">7706</td><td align="left" style="shaded" rowspan="1" colspan="1">7727</td><td align="left" style="shaded" rowspan="1" colspan="1">195</td><td align="left" style="shaded" rowspan="1" colspan="1">66</td></tr><tr><td align="left" rowspan="2" colspan="1">MDV1-M12-3p</td><td align="left" rowspan="1" colspan="1">TTGCATAATACGGAGGGTTCTGT</td><td align="left" rowspan="1" colspan="1">23</td><td align="left" rowspan="1" colspan="1">7672</td><td align="left" rowspan="1" colspan="1">7694</td><td align="left" rowspan="1" colspan="1">5,136,011</td><td align="left" rowspan="1" colspan="1">73</td></tr><tr><td align="left" rowspan="1" colspan="1">TGCATAATACGGAGGGTTCTGT</td><td align="left" rowspan="1" colspan="1">22</td><td align="left" rowspan="1" colspan="1">7672</td><td align="left" rowspan="1" colspan="1">7693</td><td align="left" rowspan="1" colspan="1">736,934</td><td align="left" rowspan="1" colspan="1">10</td></tr><tr><td align="left" style="shaded" rowspan="1" colspan="1">MDV1-M31-5p</td><td align="left" style="shaded" rowspan="1" colspan="1">GGCCAGCTCACTGGCTGTGCACT</td><td align="left" style="shaded" rowspan="1" colspan="1">23</td><td align="left" style="shaded" rowspan="1" colspan="1">5053</td><td align="left" style="shaded" rowspan="1" colspan="1">5075</td><td align="left" style="shaded" rowspan="1" colspan="1">368</td><td align="left" style="shaded" rowspan="1" colspan="1">68</td></tr><tr><td align="left" rowspan="3" colspan="1">MDV1-M31-3p</td><td align="left" rowspan="1" colspan="1">TGCTACAGTCGTGAGCAGATCAA</td><td align="left" rowspan="1" colspan="1">23</td><td align="left" rowspan="1" colspan="1">5016</td><td align="left" rowspan="1" colspan="1">5038</td><td align="left" rowspan="1" colspan="1">25,188</td><td align="left" rowspan="1" colspan="1">30</td></tr><tr><td align="left" rowspan="1" colspan="1">TGCTACAGTCGTGAGCAGATC</td><td align="left" rowspan="1" colspan="1">21</td><td align="left" rowspan="1" colspan="1">5018</td><td align="left" rowspan="1" colspan="1">5038</td><td align="left" rowspan="1" colspan="1">19,551</td><td align="left" rowspan="1" colspan="1">23</td></tr><tr><td align="left" rowspan="1" colspan="1">TGCTACAGTCGTGAGCAGATCA</td><td align="left" rowspan="1" colspan="1">22</td><td align="left" rowspan="1" colspan="1">5017</td><td align="left" rowspan="1" colspan="1">5038</td><td align="left" rowspan="1" colspan="1">16,728</td><td align="left" rowspan="1" colspan="1">20</td></tr></tbody></table><table-wrap-foot><fn id="ngtab1.1"><label><sup>a</sup></label><p>List of MDV-1 miRNAs detected by deep sequencing showing their prevalence as well as all the viral miRNA isoforms that contribute &#x02265;10% of the total reads for that miRNA.</p></fn></table-wrap-foot></table-wrap><table-wrap id="tab2" position="float"><label>TABLE&#x000a0;2&#x000a0;</label><caption><p>MDV-2 miRNAs expressed in MSB-1 cells<sup><xref rid="ngtab2.1"><italic>a</italic></xref></sup></p></caption><table frame="hsides" rules="groups"><thead valign="bottom"><tr><th align="left" rowspan="2" colspan="1">miRNA</th><th align="left" rowspan="2" colspan="1">Sequence</th><th align="left" rowspan="2" colspan="1">Length</th><th align="left" colspan="2" rowspan="1">Position<hr/></th><th align="left" rowspan="2" colspan="1">Frequency</th><th align="left" rowspan="2" colspan="1">%</th></tr><tr><th align="left" rowspan="1" colspan="1">Beginning</th><th align="left" rowspan="1" colspan="1">End</th></tr></thead><tbody valign="top"><tr><td align="left" style="shaded" rowspan="1" colspan="1">MDV2-M14-5p</td><td align="left" style="shaded" rowspan="1" colspan="1">GTGTGGTACGGTGCACCCTGAGA</td><td align="left" style="shaded" rowspan="1" colspan="1">23</td><td align="left" style="shaded" rowspan="1" colspan="1">6911</td><td align="left" style="shaded" rowspan="1" colspan="1">6933</td><td align="left" style="shaded" rowspan="1" colspan="1">85,064</td><td align="left" style="shaded" rowspan="1" colspan="1">31</td></tr><tr><td align="left" style="shaded" rowspan="1" colspan="1"/><td align="left" style="shaded" rowspan="1" colspan="1">TGTGGTACGGTGCACCCTGAGA</td><td align="left" style="shaded" rowspan="1" colspan="1">22</td><td align="left" style="shaded" rowspan="1" colspan="1">6911</td><td align="left" style="shaded" rowspan="1" colspan="1">6932</td><td align="left" style="shaded" rowspan="1" colspan="1">84,422</td><td align="left" style="shaded" rowspan="1" colspan="1">31</td></tr><tr><td align="left" rowspan="1" colspan="1">MDV2-M14-3p</td><td align="left" rowspan="1" colspan="1">TCAGGAAGTTCCGTGCCCGAA</td><td align="left" rowspan="1" colspan="1">21</td><td align="left" rowspan="1" colspan="1">6876</td><td align="left" rowspan="1" colspan="1">6896</td><td align="left" rowspan="1" colspan="1">7,775</td><td align="left" rowspan="1" colspan="1">37</td></tr><tr><td align="left" style="shaded" rowspan="1" colspan="1">MDV2-M15-5p</td><td align="left" style="shaded" rowspan="1" colspan="1">TGGAAGGGAAAGGCAAACCGGA</td><td align="left" style="shaded" rowspan="1" colspan="1">22</td><td align="left" style="shaded" rowspan="1" colspan="1">6683</td><td align="left" style="shaded" rowspan="1" colspan="1">6703</td><td align="left" style="shaded" rowspan="1" colspan="1">3,270</td><td align="left" style="shaded" rowspan="1" colspan="1">71</td></tr><tr><td align="left" rowspan="1" colspan="1">MDV2-M15-3p</td><td align="left" rowspan="1" colspan="1">TGTGTTTTTCCCTTCCATCGCA</td><td align="left" rowspan="1" colspan="1">22</td><td align="left" rowspan="1" colspan="1">6640</td><td align="left" rowspan="1" colspan="1">6661</td><td align="left" rowspan="1" colspan="1">343,988</td><td align="left" rowspan="1" colspan="1">71</td></tr><tr><td align="left" style="shaded" rowspan="1" colspan="1">MDV2-M16-5p</td><td align="left" style="shaded" rowspan="1" colspan="1">ATCCAGTCTGTTTTGGCATCTGA</td><td align="left" style="shaded" rowspan="1" colspan="1">23</td><td align="left" style="shaded" rowspan="1" colspan="1">5547</td><td align="left" style="shaded" rowspan="1" colspan="1">5569</td><td align="left" style="shaded" rowspan="1" colspan="1">1,323,176</td><td align="left" style="shaded" rowspan="1" colspan="1">73</td></tr><tr><td align="left" rowspan="1" colspan="1">MDV2-M16-3p</td><td align="left" rowspan="1" colspan="1">AGATGCCAGAGAGACTGAAAT</td><td align="left" rowspan="1" colspan="1">21</td><td align="left" rowspan="1" colspan="1">5507</td><td align="left" rowspan="1" colspan="1">5527</td><td align="left" rowspan="1" colspan="1">430</td><td align="left" rowspan="1" colspan="1">41</td></tr><tr><td align="left" style="shaded" rowspan="1" colspan="1">MDV2-M17-5p</td><td align="left" style="shaded" rowspan="1" colspan="1">AGTCCTTCCCGGGTCCCCTAGA</td><td align="left" style="shaded" rowspan="1" colspan="1">22</td><td align="left" style="shaded" rowspan="1" colspan="1">5160</td><td align="left" style="shaded" rowspan="1" colspan="1">5181</td><td align="left" style="shaded" rowspan="1" colspan="1">183,305</td><td align="left" style="shaded" rowspan="1" colspan="1">76</td></tr><tr><td align="left" rowspan="1" colspan="1">MDV2-M17-3p</td><td align="left" rowspan="1" colspan="1">TAGGACAACCGGGACGGACAGG</td><td align="left" rowspan="1" colspan="1">22</td><td align="left" rowspan="1" colspan="1">5126</td><td align="left" rowspan="1" colspan="1">5147</td><td align="left" rowspan="1" colspan="1">201,610</td><td align="left" rowspan="1" colspan="1">66</td></tr><tr><td align="left" rowspan="3" style="shaded" colspan="1">MDV2-M18-5p</td><td align="left" style="shaded" rowspan="1" colspan="1">GTTTTCTCTCAGGCTGGCATTGC</td><td align="left" style="shaded" rowspan="1" colspan="1">23</td><td align="left" style="shaded" rowspan="1" colspan="1">5001</td><td align="left" style="shaded" rowspan="1" colspan="1">5023</td><td align="left" style="shaded" rowspan="1" colspan="1">214,786</td><td align="left" style="shaded" rowspan="1" colspan="1">31</td></tr><tr><td align="left" style="shaded" rowspan="1" colspan="1">GTTTTCTCTCAGGCTGGCATTGCA</td><td align="left" style="shaded" rowspan="1" colspan="1">24</td><td align="left" style="shaded" rowspan="1" colspan="1">5000</td><td align="left" style="shaded" rowspan="1" colspan="1">5023</td><td align="left" style="shaded" rowspan="1" colspan="1">150,712</td><td align="left" style="shaded" rowspan="1" colspan="1">22</td></tr><tr><td align="left" style="shaded" rowspan="1" colspan="1">TGTTTTCTCTCAGGCTGGCATTGC</td><td align="left" style="shaded" rowspan="1" colspan="1">24</td><td align="left" style="shaded" rowspan="1" colspan="1">5001</td><td align="left" style="shaded" rowspan="1" colspan="1">5024</td><td align="left" style="shaded" rowspan="1" colspan="1">99,695</td><td align="left" style="shaded" rowspan="1" colspan="1">14</td></tr><tr><td align="left" rowspan="1" colspan="1">MDV2-M18-3p</td><td align="left" rowspan="1" colspan="1">CAATGCCTGCGGAGAGAAAGA</td><td align="left" rowspan="1" colspan="1">21</td><td align="left" rowspan="1" colspan="1">4961</td><td align="left" rowspan="1" colspan="1">4981</td><td align="left" rowspan="1" colspan="1">10,011</td><td align="left" rowspan="1" colspan="1">70</td></tr><tr><td align="left" rowspan="4" style="shaded" colspan="1">MDV2-M19-5p</td><td align="left" style="shaded" rowspan="1" colspan="1">CCCCTCGGCGGTGTGCACGGG</td><td align="left" style="shaded" rowspan="1" colspan="1">21</td><td align="left" style="shaded" rowspan="1" colspan="1">4844</td><td align="left" style="shaded" rowspan="1" colspan="1">4864</td><td align="left" style="shaded" rowspan="1" colspan="1">1,267</td><td align="left" style="shaded" rowspan="1" colspan="1">53</td></tr><tr><td align="left" style="shaded" rowspan="1" colspan="1">CCCCTCGGCGGTGTGCACGG</td><td align="left" style="shaded" rowspan="1" colspan="1">20</td><td align="left" style="shaded" rowspan="1" colspan="1">4845</td><td align="left" style="shaded" rowspan="1" colspan="1">4864</td><td align="left" style="shaded" rowspan="1" colspan="1">408</td><td align="left" style="shaded" rowspan="1" colspan="1">17</td></tr><tr><td align="left" style="shaded" rowspan="1" colspan="1">CCCCTCGGCGGTGTGCACGGGT</td><td align="left" style="shaded" rowspan="1" colspan="1">22</td><td align="left" style="shaded" rowspan="1" colspan="1">4844</td><td align="left" style="shaded" rowspan="1" colspan="1">4865</td><td align="left" style="shaded" rowspan="1" colspan="1">349</td><td align="left" style="shaded" rowspan="1" colspan="1">14</td></tr><tr><td align="left" style="shaded" rowspan="1" colspan="1">CCCCTCGGCGGTGTGCACGGGA</td><td align="left" style="shaded" rowspan="1" colspan="1">22</td><td align="left" style="shaded" rowspan="1" colspan="1">4843</td><td align="left" style="shaded" rowspan="1" colspan="1">4864</td><td align="left" style="shaded" rowspan="1" colspan="1">249</td><td align="left" style="shaded" rowspan="1" colspan="1">10</td></tr><tr><td align="left" rowspan="1" colspan="1">MDV2-M19-3p</td><td align="left" rowspan="1" colspan="1">CATGCCCCCCTCCGAGGGTAGC</td><td align="left" rowspan="1" colspan="1">22</td><td align="left" rowspan="1" colspan="1">4804</td><td align="left" rowspan="1" colspan="1">4825</td><td align="left" rowspan="1" colspan="1">353</td><td align="left" rowspan="1" colspan="1">85</td></tr><tr><td align="left" rowspan="2" style="shaded" colspan="1">MDV2-M20-5p</td><td align="left" style="shaded" rowspan="1" colspan="1">TCCTTAGCGTGGTGCCTGAGA</td><td align="left" style="shaded" rowspan="1" colspan="1">21</td><td align="left" style="shaded" rowspan="1" colspan="1">4694</td><td align="left" style="shaded" rowspan="1" colspan="1">4714</td><td align="left" style="shaded" rowspan="1" colspan="1">555,354</td><td align="left" style="shaded" rowspan="1" colspan="1">73</td></tr><tr><td align="left" style="shaded" rowspan="1" colspan="1">TCCTTAGCGTGGTGCCTGAG</td><td align="left" style="shaded" rowspan="1" colspan="1">20</td><td align="left" style="shaded" rowspan="1" colspan="1">4696</td><td align="left" style="shaded" rowspan="1" colspan="1">4715</td><td align="left" style="shaded" rowspan="1" colspan="1">77,179</td><td align="left" style="shaded" rowspan="1" colspan="1">10</td></tr><tr><td align="left" rowspan="1" colspan="1">MDV2-M20-3p</td><td align="left" rowspan="1" colspan="1">TCAAGTACTGCGCGCAAGGACCG</td><td align="left" rowspan="1" colspan="1">23</td><td align="left" rowspan="1" colspan="1">4654</td><td align="left" rowspan="1" colspan="1">4676</td><td align="left" rowspan="1" colspan="1">101,333</td><td align="left" rowspan="1" colspan="1">52</td></tr><tr><td align="left" style="shaded" rowspan="1" colspan="1">MDV2-M21-5p</td><td align="left" style="shaded" rowspan="1" colspan="1">TCCTCCTTCGCGGGGTGCTTGA</td><td align="left" style="shaded" rowspan="1" colspan="1">22</td><td align="left" style="shaded" rowspan="1" colspan="1">4559</td><td align="left" style="shaded" rowspan="1" colspan="1">4580</td><td align="left" style="shaded" rowspan="1" colspan="1">175,317</td><td align="left" style="shaded" rowspan="1" colspan="1">74</td></tr><tr><td align="left" rowspan="1" colspan="1">MDV2-M21-3p</td><td align="left" rowspan="1" colspan="1">GAGCACCACGCCGATGGACGGAG</td><td align="left" rowspan="1" colspan="1">23</td><td align="left" rowspan="1" colspan="1">4517</td><td align="left" rowspan="1" colspan="1">4539</td><td align="left" rowspan="1" colspan="1">9,299</td><td align="left" rowspan="1" colspan="1">28</td></tr><tr><td align="left" rowspan="2" style="shaded" colspan="1">MDV2-M22-5p</td><td align="left" style="shaded" rowspan="1" colspan="1">TCTTACACGCACGTCACTCTGGT</td><td align="left" style="shaded" rowspan="1" colspan="1">23</td><td align="left" style="shaded" rowspan="1" colspan="1">4279</td><td align="left" style="shaded" rowspan="1" colspan="1">4301</td><td align="left" style="shaded" rowspan="1" colspan="1">314,713</td><td align="left" style="shaded" rowspan="1" colspan="1">49</td></tr><tr><td align="left" style="shaded" rowspan="1" colspan="1">TCTTACACGCACGTCACTCTGGTC</td><td align="left" style="shaded" rowspan="1" colspan="1">24</td><td align="left" style="shaded" rowspan="1" colspan="1">4278</td><td align="left" style="shaded" rowspan="1" colspan="1">4301</td><td align="left" style="shaded" rowspan="1" colspan="1">200,784</td><td align="left" style="shaded" rowspan="1" colspan="1">32</td></tr><tr><td align="left" rowspan="1" colspan="1">MDV2-M22-3p</td><td align="left" rowspan="1" colspan="1">AGTGGCTTGCTTGTAGGCTGT</td><td align="left" rowspan="1" colspan="1">21</td><td align="left" rowspan="1" colspan="1">4243</td><td align="left" rowspan="1" colspan="1">4263</td><td align="left" rowspan="1" colspan="1">12,183</td><td align="left" rowspan="1" colspan="1">22</td></tr><tr><td align="left" style="shaded" rowspan="1" colspan="1">MDV2-M23-5p</td><td align="left" style="shaded" rowspan="1" colspan="1">ATGGTCCGTGGTACGGTGTCCT</td><td align="left" style="shaded" rowspan="1" colspan="1">22</td><td align="left" style="shaded" rowspan="1" colspan="1">4130</td><td align="left" style="shaded" rowspan="1" colspan="1">4151</td><td align="left" style="shaded" rowspan="1" colspan="1">2,266</td><td align="left" style="shaded" rowspan="1" colspan="1">54</td></tr><tr><td align="left" rowspan="1" colspan="1">MDV2-M23-3p</td><td align="left" rowspan="1" colspan="1">GTCTCCGTACACCGGACCATCG</td><td align="left" rowspan="1" colspan="1">22</td><td align="left" rowspan="1" colspan="1">4094</td><td align="left" rowspan="1" colspan="1">4115</td><td align="left" rowspan="1" colspan="1">2,975</td><td align="left" rowspan="1" colspan="1">48</td></tr><tr><td align="left" style="shaded" rowspan="1" colspan="1">MDV2-M24-5p</td><td align="left" style="shaded" rowspan="1" colspan="1">TTTTTCCCTTACGGTGCCTGACG</td><td align="left" style="shaded" rowspan="1" colspan="1">23</td><td align="left" style="shaded" rowspan="1" colspan="1">3539</td><td align="left" style="shaded" rowspan="1" colspan="1">3561</td><td align="left" style="shaded" rowspan="1" colspan="1">96,126</td><td align="left" style="shaded" rowspan="1" colspan="1">75</td></tr><tr><td align="left" rowspan="2" colspan="1">MDV2-M24-3p</td><td align="left" rowspan="1" colspan="1">TTAGATGCCGTCAGGGAAAGAT</td><td align="left" rowspan="1" colspan="1">22</td><td align="left" rowspan="1" colspan="1">3503</td><td align="left" rowspan="1" colspan="1">3524</td><td align="left" rowspan="1" colspan="1">202,003</td><td align="left" rowspan="1" colspan="1">62</td></tr><tr><td align="left" rowspan="1" colspan="1">TAGATGCCGTCAGGGAAAGATG</td><td align="left" rowspan="1" colspan="1">22</td><td align="left" rowspan="1" colspan="1">3502</td><td align="left" rowspan="1" colspan="1">3523</td><td align="left" rowspan="1" colspan="1">42,917</td><td align="left" rowspan="1" colspan="1">13</td></tr><tr><td align="left" rowspan="4" style="shaded" colspan="1">MDV2-M25-5p</td><td align="left" style="shaded" rowspan="1" colspan="1">CCTCCTTCGGACGAGTGCTTGCC</td><td align="left" style="shaded" rowspan="1" colspan="1">23</td><td align="left" style="shaded" rowspan="1" colspan="1">3391</td><td align="left" style="shaded" rowspan="1" colspan="1">3413</td><td align="left" style="shaded" rowspan="1" colspan="1">430</td><td align="left" style="shaded" rowspan="1" colspan="1">24</td></tr><tr><td align="left" style="shaded" rowspan="1" colspan="1">CCTCCTTCGGACGAGTGCTTGC</td><td align="left" style="shaded" rowspan="1" colspan="1">22</td><td align="left" style="shaded" rowspan="1" colspan="1">3391</td><td align="left" style="shaded" rowspan="1" colspan="1">3412</td><td align="left" style="shaded" rowspan="1" colspan="1">412</td><td align="left" style="shaded" rowspan="1" colspan="1">23</td></tr><tr><td align="left" style="shaded" rowspan="1" colspan="1">CCTCCTTCGGACGAGTGCTTGCCG</td><td align="left" style="shaded" rowspan="1" colspan="1">24</td><td align="left" style="shaded" rowspan="1" colspan="1">3391</td><td align="left" style="shaded" rowspan="1" colspan="1">3414</td><td align="left" style="shaded" rowspan="1" colspan="1">383</td><td align="left" style="shaded" rowspan="1" colspan="1">21</td></tr><tr><td align="left" style="shaded" rowspan="1" colspan="1">TCCTTCGGACGAGTGCTTGCCG</td><td align="left" style="shaded" rowspan="1" colspan="1">22</td><td align="left" style="shaded" rowspan="1" colspan="1">3393</td><td align="left" style="shaded" rowspan="1" colspan="1">3414</td><td align="left" style="shaded" rowspan="1" colspan="1">237</td><td align="left" style="shaded" rowspan="1" colspan="1">13</td></tr><tr><td align="left" rowspan="1" colspan="1">MDV2-M25-3p</td><td align="left" rowspan="1" colspan="1">TGCACTACTCCGGGGGTAGGAC</td><td align="left" rowspan="1" colspan="1">22</td><td align="left" rowspan="1" colspan="1">3353</td><td align="left" rowspan="1" colspan="1">3374</td><td align="left" rowspan="1" colspan="1">291</td><td align="left" rowspan="1" colspan="1">24</td></tr><tr><td align="left" style="shaded" rowspan="1" colspan="1">MDV2-M26-5p</td><td align="left" style="shaded" rowspan="1" colspan="1">TCCTTTGTGCTGTGTGTGAGA</td><td align="left" style="shaded" rowspan="1" colspan="1">21</td><td align="left" style="shaded" rowspan="1" colspan="1">3258</td><td align="left" style="shaded" rowspan="1" colspan="1">3278</td><td align="left" style="shaded" rowspan="1" colspan="1">49,552</td><td align="left" style="shaded" rowspan="1" colspan="1">78</td></tr><tr><td align="left" rowspan="4" colspan="1">MDV2-M26-3p</td><td align="left" rowspan="1" colspan="1">TCGGGCACCGCACCGAAGGATG</td><td align="left" rowspan="1" colspan="1">22</td><td align="left" rowspan="1" colspan="1">3221</td><td align="left" rowspan="1" colspan="1">3243</td><td align="left" rowspan="1" colspan="1">8,940</td><td align="left" rowspan="1" colspan="1">36</td></tr><tr><td align="left" rowspan="1" colspan="1">TCGGGCACCGCACCGAAGGATGT</td><td align="left" rowspan="1" colspan="1">23</td><td align="left" rowspan="1" colspan="1">3221</td><td align="left" rowspan="1" colspan="1">3243</td><td align="left" rowspan="1" colspan="1">3,992</td><td align="left" rowspan="1" colspan="1">16</td></tr><tr><td align="left" rowspan="1" colspan="1">TCGGGCACCGCACCGAAGGAT</td><td align="left" rowspan="1" colspan="1">21</td><td align="left" rowspan="1" colspan="1">3223</td><td align="left" rowspan="1" colspan="1">3243</td><td align="left" rowspan="1" colspan="1">3,531</td><td align="left" rowspan="1" colspan="1">14</td></tr><tr><td align="left" rowspan="1" colspan="1">TCGGGCACCGCACCGAAGGATT</td><td align="left" rowspan="1" colspan="1">22</td><td align="left" rowspan="1" colspan="1">3222</td><td align="left" rowspan="1" colspan="1">3243</td><td align="left" rowspan="1" colspan="1">3,480</td><td align="left" rowspan="1" colspan="1">14</td></tr><tr><td align="left" rowspan="2" style="shaded" colspan="1">MDV2-M27-5p</td><td align="left" style="shaded" rowspan="1" colspan="1">CTTCGTCCGGTGTTCGAGGCG</td><td align="left" style="shaded" rowspan="1" colspan="1">21</td><td align="left" style="shaded" rowspan="1" colspan="1">3121</td><td align="left" style="shaded" rowspan="1" colspan="1">3141</td><td align="left" style="shaded" rowspan="1" colspan="1">50,748</td><td align="left" style="shaded" rowspan="1" colspan="1">67</td></tr><tr><td align="left" style="shaded" rowspan="1" colspan="1">CTTCGTCCGGTGTTCGAGGCGT</td><td align="left" style="shaded" rowspan="1" colspan="1">22</td><td align="left" style="shaded" rowspan="1" colspan="1">3120</td><td align="left" style="shaded" rowspan="1" colspan="1">3141</td><td align="left" style="shaded" rowspan="1" colspan="1">15,467</td><td align="left" style="shaded" rowspan="1" colspan="1">20</td></tr><tr><td align="left" rowspan="2" colspan="1">MDV2-M27-3p</td><td align="left" rowspan="1" colspan="1">CGTCGAGCACCGTGCTGGAGGA</td><td align="left" rowspan="1" colspan="1">22</td><td align="left" rowspan="1" colspan="1">3080</td><td align="left" rowspan="1" colspan="1">3101</td><td align="left" rowspan="1" colspan="1">46,233</td><td align="left" rowspan="1" colspan="1">62</td></tr><tr><td align="left" rowspan="1" colspan="1">CGTCGAGCACCGTGCTGGAGGAA</td><td align="left" rowspan="1" colspan="1">23</td><td align="left" rowspan="1" colspan="1">3079</td><td align="left" rowspan="1" colspan="1">3101</td><td align="left" rowspan="1" colspan="1">13,163</td><td align="left" rowspan="1" colspan="1">18</td></tr><tr><td align="left" rowspan="4" style="shaded" colspan="1">MDV2-M28-5p</td><td align="left" style="shaded" rowspan="1" colspan="1">TTCTCGACGCCTACCCTCGGC</td><td align="left" style="shaded" rowspan="1" colspan="1">21</td><td align="left" style="shaded" rowspan="1" colspan="1">2901</td><td align="left" style="shaded" rowspan="1" colspan="1">2921</td><td align="left" style="shaded" rowspan="1" colspan="1">489,862</td><td align="left" style="shaded" rowspan="1" colspan="1">36</td></tr><tr><td align="left" style="shaded" rowspan="1" colspan="1">TTTTCTCGACGCCTACCCTCGGC</td><td align="left" style="shaded" rowspan="1" colspan="1">23</td><td align="left" style="shaded" rowspan="1" colspan="1">2901</td><td align="left" style="shaded" rowspan="1" colspan="1">2923</td><td align="left" style="shaded" rowspan="1" colspan="1">226,111</td><td align="left" style="shaded" rowspan="1" colspan="1">16</td></tr><tr><td align="left" style="shaded" rowspan="1" colspan="1">TTCTCGACGCCTACCCTCGGCG</td><td align="left" style="shaded" rowspan="1" colspan="1">22</td><td align="left" style="shaded" rowspan="1" colspan="1">2900</td><td align="left" style="shaded" rowspan="1" colspan="1">2921</td><td align="left" style="shaded" rowspan="1" colspan="1">182,831</td><td align="left" style="shaded" rowspan="1" colspan="1">13</td></tr><tr><td align="left" style="shaded" rowspan="1" colspan="1">TTTTCTCGACGCCTACCCTCGG</td><td align="left" style="shaded" rowspan="1" colspan="1">22</td><td align="left" style="shaded" rowspan="1" colspan="1">2902</td><td align="left" style="shaded" rowspan="1" colspan="1">2923</td><td align="left" style="shaded" rowspan="1" colspan="1">151,642</td><td align="left" style="shaded" rowspan="1" colspan="1">11</td></tr><tr><td align="left" rowspan="1" colspan="1">MDV2-M28-3p</td><td align="left" rowspan="1" colspan="1">CCGAGGGTAGGCGCAGAGGA</td><td align="left" rowspan="1" colspan="1">20</td><td align="left" rowspan="1" colspan="1">2870</td><td align="left" rowspan="1" colspan="1">2889</td><td align="left" rowspan="1" colspan="1">1,242</td><td align="left" rowspan="1" colspan="1">20</td></tr><tr><td align="left" style="shaded" rowspan="1" colspan="1">MDV2-M29-5p</td><td align="left" style="shaded" rowspan="1" colspan="1">TCTTCACGTACCTCTCTATGGC</td><td align="left" style="shaded" rowspan="1" colspan="1">22</td><td align="left" style="shaded" rowspan="1" colspan="1">2758</td><td align="left" style="shaded" rowspan="1" colspan="1">2779</td><td align="left" style="shaded" rowspan="1" colspan="1">4,704,329</td><td align="left" style="shaded" rowspan="1" colspan="1">72</td></tr><tr><td align="left" rowspan="1" colspan="1">MDV2-M29-3p</td><td align="left" rowspan="1" colspan="1">CATAGTGAGGTACGTGTAGG</td><td align="left" rowspan="1" colspan="1">20</td><td align="left" rowspan="1" colspan="1">2724</td><td align="left" rowspan="1" colspan="1">2743</td><td align="left" rowspan="1" colspan="1">1,522</td><td align="left" rowspan="1" colspan="1">42</td></tr><tr><td align="left" rowspan="2" style="shaded" colspan="1">MDV2-M30-5p</td><td align="left" style="shaded" rowspan="1" colspan="1">CAACACTCCCTCGGACGCAGCA</td><td align="left" style="shaded" rowspan="1" colspan="1">22</td><td align="left" style="shaded" rowspan="1" colspan="1">160933</td><td align="left" style="shaded" rowspan="1" colspan="1">160954</td><td align="left" style="shaded" rowspan="1" colspan="1">372,131</td><td align="left" style="shaded" rowspan="1" colspan="1">58</td></tr><tr><td align="left" style="shaded" rowspan="1" colspan="1">CAACACTCCCTCGGACGCAGC</td><td align="left" style="shaded" rowspan="1" colspan="1">21</td><td align="left" style="shaded" rowspan="1" colspan="1">160934</td><td align="left" style="shaded" rowspan="1" colspan="1">160954</td><td align="left" style="shaded" rowspan="1" colspan="1">152,551</td><td align="left" style="shaded" rowspan="1" colspan="1">24</td></tr><tr><td align="left" rowspan="1" colspan="1">MDV2-M30-3p</td><td align="left" rowspan="1" colspan="1">CTGACGTGCGAGGGAGTGCTCG</td><td align="left" rowspan="1" colspan="1">22</td><td align="left" rowspan="1" colspan="1">160897</td><td align="left" rowspan="1" colspan="1">160918</td><td align="left" rowspan="1" colspan="1">1,808</td><td align="left" rowspan="1" colspan="1">67</td></tr><tr><td align="left" style="shaded" rowspan="1" colspan="1">MDV2-M32-5p</td><td align="left" style="shaded" rowspan="1" colspan="1">ATTCCATCCTTCGACTAGCGACT</td><td align="left" style="shaded" rowspan="1" colspan="1">23</td><td align="left" style="shaded" rowspan="1" colspan="1">5387</td><td align="left" style="shaded" rowspan="1" colspan="1">5409</td><td align="left" style="shaded" rowspan="1" colspan="1">415</td><td align="left" style="shaded" rowspan="1" colspan="1">94</td></tr><tr><td align="left" rowspan="1" colspan="1">MDV2-M32-3p</td><td align="left" rowspan="1" colspan="1">TAATAGCCGGACGACGGAGTCT</td><td align="left" rowspan="1" colspan="1">22</td><td align="left" rowspan="1" colspan="1">5353</td><td align="left" rowspan="1" colspan="1">5374</td><td align="left" rowspan="1" colspan="1">23,910</td><td align="left" rowspan="1" colspan="1">91</td></tr></tbody></table><table-wrap-foot><fn id="ngtab2.1"><label><sup>a</sup></label><p>As in <xref ref-type="table" rid="tab1">Table&#x000a0;1</xref>, but showing all observed MDV-2 miRNAs and their isoforms.</p></fn></table-wrap-foot></table-wrap></sec><sec id="h1.2"><title>The mRNA targetome of MDV microRNAs.</title><p>Having identified all viral miRNA species expressed in the MSB1 lymphoblastoid cell line, we next sought to identify the cellular and viral mRNA populations targeted by these miRNAs using the previously described photoactivatable ribonucleoside-enhanced cross-linking and immunoprecipitation (PAR-CLIP) procedure (<xref rid="B28" ref-type="bibr">28</xref>, <xref rid="B29" ref-type="bibr">29</xref>, <xref rid="B32" ref-type="bibr">32</xref>). For this purpose, MSB1 transcripts were labeled by growth of cells in 4-thiouridine, followed by cross-linking of RNAs to bound proteins by irradiation at 365&#x000a0;nm. After lysis, RNA fragments bound to RISC were isolated by immunoprecipitation using a pan-Ago antibody followed by RNase treatment, linker ligation, reverse transcription, PCR amplification, and deep sequencing. Analysis of the PAR-CLIP reads obtained, using the previously described PARalyzer software (<xref rid="B34" ref-type="bibr">34</xref>), identified 16,585 RISC-binding clusters which mapped primarily to mRNA coding regions, 3&#x02032; UTRs, and intergenic regions (<xref ref-type="fig" rid="fig2">Fig.&#x000a0;2A</xref>). (Note that the chicken transcriptome is currently not well defined, so intergenic regions are expected to be overrepresented.) A list of all RISC binding clusters identified, with their predicted miRNAs, is given in <xref ref-type="supplementary-material" rid="tabS1">Table S1</xref> in the supplemental material. Of these 16,585 binding clusters, PARalyzer predicted 1,104 cellular mRNAs that were bound by one or more MDV-1 miRNAs, while 1,183 cellular mRNAs were predicted to be bound by one or more MDV-2 miRNAs. The lack of correlation between the relative abundance of the MDV-1 and MDV-2 miRNAs (<xref ref-type="fig" rid="fig1">Fig.&#x000a0;1A</xref>) and the number of miRNA binding clusters, while to some extent unexpected, has nevertheless also been observed in previous efforts to define miRNA target sites using CLIP (<xref rid="B36" ref-type="bibr">36</xref>). Of these viral miRNA binding clusters, 419 (~38%) were predicted to be targeted by both MDV-1- and MDV-2-encoded miRNAs (<xref ref-type="fig" rid="fig2">Fig.&#x000a0;2B</xref>). Of note, PARalyzer also predicted that MDV-1 miR-M3-5p, miR-M7-5p, and miR-M12-3p, as well as MDV-2 miR-M14-5p, miR-M18-5p, miR-M24-3p, and miR-M28-5p, all of which exist in two isoforms differing at their 5&#x02032; ends (<xref ref-type="table" rid="tab1 tab2">Tables&#x000a0;1 and 2</xref> and <xref ref-type="fig" rid="fig2">Fig.&#x000a0;2C</xref>) bind to two overlapping but distinct sets of mRNA targets in MSB1 cells, due to their two different seed sequences. Whether the ability of these miRNAs to extend their mRNA targetome by generating two distinct miRNA 5&#x02032; isoforms is important for MDV-1 and/or MDV-2 replication is not currently known.</p><fig id="fig2" position="float"><label>FIG&#x000a0;2&#x000a0;</label><caption><p>Characterization of the MSB1 PAR-CLIP Library. (A) Annotation of PAR-CLIP clusters that align to a miRNA seed in terms of their genomic origin. (B) Overlapping cellular mRNA targets (coding region plus 3&#x02032; UTR plus 500-bp extension) of the MDV-1 and MDV-2 miRNAs. (C) Number of predicted mRNA targets of viral miRNAs that show 5&#x02032;-end variation and hence have two different seeds.</p></caption><graphic xlink:href="mbo0011417180002"/></fig></sec><sec id="h1.3"><title>Viral mRNA targets of MDV-1 and MDV-2 miRNAs.</title><p>Analysis of miRNA binding clusters on the MDV-1 genome identified five very strong binding clusters between positions ~7200 and ~7800, near the 5&#x02032; end of the MDV-1 genome (<xref ref-type="fig" rid="fig3">Fig.&#x000a0;3A</xref>). These clusters essentially coincide with, but are antisense to, the highly expressed MDV-1 miRNAs miR-M2, miR-M3, miR-M4, and miR-M12, which are adjacent to each other and all located antisense to an MDV-1 mRNA that encodes the viral RLORF8 protein (<xref ref-type="fig" rid="fig3">Fig.&#x000a0;3A</xref>). Similarly, we also detected very strong binding clusters near the 5&#x02032; end of the MDV-2 genome, coincident with, but antisense to, the MDV-2 miRNAs miR-M24, miR-M28, and miR-M29. Again, these are located antisense to an MDV-2 gene, in this case RLORF2 (<xref ref-type="fig" rid="fig3">Fig.&#x000a0;3B</xref>). Previously, we have reported that miRNAs encoded by HSV-1 that are located antisense to the viral immediate early protein ICP0 or the late viral protein ICP34.5 not only give rise to readily detectable miRNA binding clusters on the cognate viral mRNA species in infected cells but also inhibit ICP0 and ICP34.5 expression (<xref rid="B8" ref-type="bibr">8</xref>, <xref rid="B37" ref-type="bibr">37</xref>). We therefore wished to determine whether the four MDV-1 miRNAs expressed antisense to RLORF8 are, in fact, able to repress RLORF8 expression. For this purpose, we generated an indicator construct containing the entire RLORF8 open reading frame and 445&#x000a0;bp of the 3&#x02032; UTR, encompassing all four predicted MDV-1 miRNA binding sites (<xref ref-type="fig" rid="fig3">Fig.&#x000a0;3A</xref>), inserted 3&#x02032; to the firefly luciferase indicator gene (<italic>fluc</italic>), as well as expression vectors encoding MDV-1 miR-M2, miR-M3, miR-M4, or miR-M12. Analogous vectors containing two perfect artificial target sites for each miRNA inserted 3&#x02032; to <italic>fluc</italic> served as positive controls. Finally, we also generated derivatives in which each predicted RLORF8 mRNA target site was mutated in the seed complement. As may be observed in <xref ref-type="fig" rid="fig4">Fig.&#x000a0;4A</xref>, cotransfection of each MDV-1 miRNA expression vector into 293T cells along with the positive-control indicator vectors resulted in a clear inhibition in FLuc expression, relative to a cotransfected <italic>Renilla</italic> luciferase (RLuc) internal control vector. Comparison of each wild-type or mutant vector containing the MDV-1 RLORF8 gene sequence showed significant down regulation of the <italic>fluc</italic> vectors containing the wild-type RLORF8 sequence by all four MDV-1 miRNAs. This inhibition was partially (miR-M2 and miR-M4) or totally (miR-M3 and miR-M12) rescued by mutation of each single antisense RLORF8 miRNA target site. These data are consistent with the hypothesis that MDV-1 mRNAs encoding RLORF8 are indeed targets for repression by some or all of these viral miRNAs.</p><fig id="fig3" position="float"><label>FIG&#x000a0;3&#x000a0;</label><caption><p>Map of RISC binding clusters that align to the MDV-1 (A) or MDV-2 (B) genome. The size of the peaks is proportional to the read depth of the clusters. A closeup of a 5&#x02032; fragment of the MDV-1 and MDV-2 genome that contains the most reads is presented. Open reading frames located on the viral plus strand are marked in blue, viral miRNAs encoded on the minus strand are marked in red, and the approximate location of relevant miRNA binding clusters, identified by PAR-CLIP, is indicated in green.</p></caption><graphic xlink:href="mbo0011417180003"/></fig><fig id="fig4" position="float"><label>FIG&#x000a0;4&#x000a0;</label><caption><p>RLORF8 expression is regulated by MDV-1 miRNAs. (A) RLORF8 and its 3&#x02032; UTR were cloned downstream of the <italic>fluc</italic> reporter gene. The level of the FLuc indicator was then measured after cotransfection into 293T cells together with the indicated MDV-1 miRNA expression vector. The FLuc-to-RLuc ratios observed for each indicator vector and miRNA were normalized to the ratio in cells that were transfected with the pLCE vector without miRNA. The values obtained in cells expressing only FLuc without a 3&#x02032; UTR were set at 100%. The error bars indicate standard deviations (SD) (<italic>n</italic> = 3). (B) We constructed <italic>fluc</italic>-based lentiviral vectors in which <italic>fluc</italic> was linked to the wild-type RLORF8 ORF and 3&#x02032; UTR, derivatives in which the MDV-1 miRNA targets in the ORF (miR-M4 and miR-M2) or 3&#x02032; UTR (miR-M3 and miR-M12) were mutated, or finally a derivative (ALL MUTANT) in which all four RLORF8 miRNA target sites were mutated. After transduction into MSB1 cells and DT40 cells, the FLuc expression ratio of MSB1 to DT40 cells was determined, and this is presented relative to the value for the &#x0201c;ALL MUTANTS&#x0201d; clone, which was set at 1.0. Data are averages for three independent samples with SD. (C) Induced expression of a mutated RLORF8 open reading frame lacking MDV-1 miRNA binding sites inhibits MSB1 growth. Data are averages from five independent experiments with SD.</p></caption><graphic xlink:href="mbo0011417180004"/></fig><p>We next generated derivatives of the above-described indicator construct, containing <italic>fluc</italic> linked to the RLORF8 open reading frame and 3&#x02032; UTR, that bore seed mutations in all four antisense MDV-1 RNA targets or only in the two targets present in either the RLORF8 open reading frame or the 3&#x02032; UTR and transduced these into MSB1 cells, or MDV-negative DT40 cells as a control. As shown in <xref ref-type="fig" rid="fig4">Fig.&#x000a0;4B</xref>, the indicator construct bearing mutations in all four of the hypothetical target sites for MDV miR-M2, -M3, -M4, and -M12, gave rise to significantly higher levels of FLuc expression than did the wild-type <italic>fluc</italic> vector, while the indicators containing mutations in only the target sites for miR-M2 and miR-M4 in the RLORF8 ORF or miR-M3 and miR-M12 in the RLORF8 3&#x02032; UTR gave intermediate phenotypes. These data again strongly suggest that RLORF8 mRNAs are bona fide targets for repression by MDV-1-encoded miRNAs and indicate that physiological levels of these viral miRNAs, expressed in MDV-1-infected cells, are sufficient to repress RLORF8 mRNA expression.</p><p>The finding that expression of the MDV-1 RLORF8 gene product is subject to suppression by as many as four different viral miRNAs suggests that RLORF8 has the potential to reduce MDV-1 replication and/or induce toxicity when expressed inappropriately. To test this hypothesis, we generated a Tet-inducible lentiviral expression vector encoding the RLORF8 open reading frame with both potential internal MDV-1 miRNA target sites mutated and used this to transduce MSB1 cells. After selection for antibiotic resistance, we then added doxycycline (Dox) to induce RLORF8 expression and compared the growth phenotype of MSB1 cells expressing ectopic RLORF8 with that of control cells transduced with a similar lentiviral vector expressing green fluorescent protein (GFP). As may be observed in <xref ref-type="fig" rid="fig4">Fig.&#x000a0;4C</xref>, MSB1 cells expressing ectopic RLORF8 indeed grew substantially more slowly than the control cells, consistent with the idea that inappropriate overexpression of RLORF8 can indeed exert a deleterious effect. We have not, however, attempted to determine the molecular basis for this effect, and to our knowledge, the role of RLORF8 in the MDV-1 life cycle remains undetermined.</p></sec><sec id="h1.4"><title>Ectopic expression of cellular mRNAs targeted by multiple MDV microRNAs.</title><p>We were intrigued by the apparent ability of ectopic RLORF8, which is targeted by four MDV-1 miRNAs in MSB1, to reduce the growth of MSB1 cells in culture and wondered if other, cellular genes that are targeted by multiple viral miRNAs might exert a similar effect. In <xref ref-type="supplementary-material" rid="tabS2">Table&#x000a0;S2</xref> in the supplemental material, we list 12 cellular genes that are targeted in their 3&#x02032; UTRs by five or more MDV-1 or MDV-2 miRNAs, as determined by PAR-CLIP. Of these, two cellular genes, encoding interleukin-18 (IL-18) and CD200R1, are predicted to be targeted by up to seven MDV-1 or MDV-2 miRNAs. IL-18 is a proinflammatory cytokine that can stimulate gamma interferon (IFN-&#x003b3;) production in T cells (<xref rid="B38" ref-type="bibr">38</xref><xref ref-type="bibr" rid="B39">&#x02013;</xref><xref rid="B40" ref-type="bibr">40</xref>), while CD200R1 is a cell surface glycoprotein generally expressed on myeloid cells (<xref rid="B41" ref-type="bibr">41</xref>) that has been proposed to play a role in the response to viral infection (<xref rid="B42" ref-type="bibr">42</xref>). Of these two genes, the IL-18 gene seemed most likely to exert an antiviral effect in culture, and this mRNA&#x02019;s 3&#x02032; UTR was predicted to be targeted by two MDV-1 miRNAs (miR-M2-3p and miR-M9-5p) and as many as five MDV-2 miRNAs (miR-M18-5p, miR-M-18-5p-1_5&#x02019;, miR-M26-5p, miR-M28-5p, and miR-M30-3p). We therefore generated Tet-inducible lentiviral vectors containing either the chicken IL-18 open reading frame or the IL-18 open frame linked to its cognate 3&#x02032; UTR, including all the predicted MDV miRNA target sites. These vectors, plus a control GFP-expressing lentivector, were transduced into MSB1 cells, and puromycin-resistant transductants were selected. These were then analyzed for their growth potential in the presence and absence of Dox (<xref ref-type="fig" rid="fig5">Fig.&#x000a0;5</xref>). As may be observed, the control transduced cells grew most rapidly, even in the presence of Dox. Cells transduced with the lentiviral vector containing the IL-18 gene linked to its 3&#x02032; UTR grew at a level comparable to that of the control in the absence of Dox but showed a significant reduction in replication in the presence of Dox. Interestingly, even in the absence of Dox, cells transduced with the chicken IL-18 expression vector lacking the IL-18 3&#x02032; UTR, and hence all five MDV miRNA target sites, clearly grew more slowly than the controls, thus suggesting that this inducible expression vector is &#x0201c;leaky&#x0201d; and expresses a low level of IL-18 even in the absence of added Dox. As one would predict, this inhibitory effect became even more severe in the presence of Dox (<xref ref-type="fig" rid="fig5">Fig.&#x000a0;5</xref>). Therefore, these data indicate that ectopic expression of chicken IL-18 reduces the replication of MSB1 cells and that this effect is greatly ameliorated if the IL-18 mRNA 3&#x02032; UTR, which is detected as a target for several MDV miRNAs by PAR-CLIP, is present in the introduced IL-18 expression vector.</p><fig id="fig5" position="float"><label>FIG&#x000a0;5&#x000a0;</label><caption><p>Ectopic expression of chicken IL-18 inhibits the growth of MSB1 cells. MSB1 cells were transduced with Dox-inducible lentiviral expression vectors that express the IL-18 gene with or without its cognate 3&#x02032; UTR under the control of a Tet-inducible promoter. Transduced cells were selected using puromycin for 2&#x000a0;weeks, and cell growth was analyzed starting 5&#x000a0;days after Dox addition. The graph is representative of three independent experiments.</p></caption><graphic xlink:href="mbo0011417180005"/></fig></sec><sec id="h1.5"><title>Conserved mRNA targets for miR-155 seed family microRNAs.</title><p>As discussed above, MDV-1 encodes a miRNA, miR-M4, that shares full seed homology not only to human and chicken miR-155 but also to the KSHV miRNA miR-K11 (<xref ref-type="fig" rid="fig6">Fig.&#x000a0;6A</xref>). Although the role of miR-K11 in transformation of B cells by KSHV remains unclear, it is known that B-cell transformation by EBV, which does not encode a miR-155 analog, is dependent on viral induction of high levels of cellular miR-155 expression (<xref rid="B26" ref-type="bibr">26</xref>). Finally, transformation of T cells by MDV-1 has been reported to require miR-M4 function (<xref rid="B27" ref-type="bibr">27</xref>). As these miR-155 seed family members all appear to play a key role in herpesviral transformation of lymphoid cells, we reasoned that we might be able to gain important insights into the underlying mechanism by identifying mRNA targets of miR-155, miR-K11, and miR-M4 that are evolutionarily conserved from chickens to humans.</p><fig id="fig6" position="float"><label>FIG&#x000a0;6&#x000a0;</label><caption><p>Conserved cellular mRNA targets of miR-M4. (A) MDV1 miR-M4 seed homology with human and chicken miR-155 and KSHV miR-K11. (B) Venn diagram of overlapping targets of miR-M4, miR-155, and KSHV miR-K11. (C) Luciferase reporter assay. 3&#x02032; UTRs of genes predicted to be targeted by MDV-1 miR-M4 were cloned with or without mutation of the predicted M4 target site into the 3&#x02032; UTR of an <italic>fluc</italic> indicator plasmid. This plasmid, together with an RLuc internal control and the relevant miRNA expression vector, was then cotransfected into 293T cells. The FLuc-to-RLuc ratios observed for each indicator vector and miRNA were normalized to the ratio in cells that were transfected with pLCE without miRNA. The values obtained with cells expressing only FLuc without 3&#x02032; UTR were set at 100%. The error bars indicate SD (<italic>n</italic> = 3).</p></caption><graphic xlink:href="mbo0011417180006"/></fig><p>A comparison of mRNA targets for miR-155, miR-K11, and miR-M4, identified by previously reported PAR-CLIP analysis of KSHV-transformed or EBV-transformed human B cells and here for MDV-1 miR-M4 in the MSB1 lymphoblastoid cell line, showed that 9 mRNA targets were detected in all three cell settings, while 4 additional mRNA targets were also conserved in both MDV-1-infected MSB1 cells and EBV-transformed lymphoblastoid cell lines (LCLs) (<xref ref-type="fig" rid="fig6">Fig.&#x000a0;6B</xref>) (see <xref ref-type="supplementary-material" rid="tabS3">Table&#x000a0;S3</xref> in the supplemental material for a full listing of mRNA targets for miR-M4 in MSB1 cells). We therefore cloned the 3&#x02032; UTRs of all nine mRNAs targeted by all three of these miR-155 seed family members as well as one additional mRNA, encoding JARID2, that is conserved between miR-155 in LCLs and miR-M4 in MSB1 cells but not in PELs. These 3&#x02032; UTRs were inserted 3&#x02032; to <italic>fluc</italic> and cotransfected into MSB1 cells along with an internal control RLuc vector. In 8 out of 10 cases, we also generated mutant derivatives of these 3&#x02032; UTRs in which the predicted MDV-1 miR-M4 target or targets (JARID2 has two predicted miR-M4 targets in its 3&#x02032; UTR) were mutated in their region of seed homology. As may be observed, we detected significant and selective repression of FLuc expression mediated by these 3&#x02032; UTRs that was partially or entirely alleviated by mutation of the predicted miR-M4/miR-155 target sites. Therefore, although these data did not reveal a statistically significant decline in response to miR-M4 and/or miR-155 expression in all cases, they are consistent with the hypothesis that targeting of the 3&#x02032; UTRs of these genes by miR-155 seed family members is conserved between humans and chickens, an evolutionary distance of ~300 million&#x000a0;years.</p></sec></sec><sec sec-type="discussion" id="h2"><title>DISCUSSION</title><p>The goal of this study was to perform an analysis of the mRNA targetomes regulated by miRNAs encoded by the oncogenic avian herpesvirus MDV-1, and its nonpathogenic relation MDV-2, and in particular to identify mRNAs targeted by MDV miR-M4, which has previously been shown to play a key role in the initiation of T-cell transformation in MDV-1 infected chickens (<xref rid="B27" ref-type="bibr">27</xref>). Our interest in miR-M4 was prompted by the previous observation that miR-M4 shows full seed homology with both the KSHV-encoded miRNA miR-K11 and with miR-155 (<xref rid="B19" ref-type="bibr">19</xref><xref ref-type="bibr" rid="B20">&#x02013;</xref><xref rid="B21" ref-type="bibr">21</xref>), a cellular miRNA that is highly conserved from birds to mammals (<xref ref-type="fig" rid="fig6">Fig.&#x000a0;6A</xref>). As discussed above, it seems highly probable that KSHV miR-K11 and human miR-155 play a key role in B-cell transformation mediated by KSHV and EBV, respectively, and, given the high conservation of miR-155 across vertebrate evolution, we therefore hypothesized that the identification of mRNA targets that are targeted by not only miR-K11 and miR-155 in human B cells but also miR-M4 in chicken lymphoblastoid cells might identify a small set of mRNAs that might play a particularly important role in lymphoid transformation by these diverse herpesviruses.</p><p>As a first step in this project, we used deep sequencing to define the viral miRNAs expressed in the chicken lymphoblastoid cell line MSB1, which is naturally infected with both MDV-1 and MDV-2. Our analysis did not identify any novel viral pre-miRNAs beyond the 13 previously identified in MDV-1 and the 18 identified in MDV-2 (<xref rid="B14" ref-type="bibr">14</xref><xref ref-type="bibr" rid="B15">&#x02013;</xref><xref rid="B18" ref-type="bibr">18</xref>). We did, however, demonstrate that several MDV-1 and MDV-2 miRNAs exist in two isoforms differing by 1 or 2&#x000a0;nt at their 5&#x02032; ends (<xref ref-type="table" rid="tab1 tab2">Tables&#x000a0;1 and 2</xref> and <xref ref-type="fig" rid="fig1">Fig.&#x000a0;1C</xref>). These viral miRNAs therefore exist in two isoforms with two different seed sequences that are predicted to target overlapping but distinct populations of mRNA transcripts. Our subsequent PAR-CLIP analysis of the mRNAs targeted by the MDV-1 and MDV-2 miRNAs expressed in MSB1 cells indicated that this was indeed the case (<xref ref-type="fig" rid="fig2">Fig.&#x000a0;2C</xref>).</p><p>PAR-CLIP identified a list of 1,104 cellular mRNAs targeted by MDV-1 miRNAs and a list of 1,183 mRNAs targeted by MDV-2 miRNAs in MSB1, of which 419 mRNA targets were shared (<xref ref-type="fig" rid="fig2">Fig.&#x000a0;2B</xref>). This is reminiscent of our previous analysis of a human PEL cell line coinfected by KSHV and EBV, which identified an extensive overlap between the cellular mRNA species targeted by EBV and KSHV miRNAs, even though these viral miRNAs lack any significant homology (<xref rid="B28" ref-type="bibr">28</xref>). This suggests that herpesviruses that target the same cell type have undergone convergent evolution leading to the expression of distinct viral miRNAs that nevertheless target overlapping sets of cellular factors via different 3&#x02032; UTR target sites.</p><p>Given the very large number of mRNA targets identified by PAR-CLIP analysis of the MDV&#x02011;1 and MDV-2 miRNA targetome (see <xref ref-type="supplementary-material" rid="tabS1">Table&#x000a0;S1</xref> in the supplemental material), we have as yet performed only a limited validation and phenotypic analysis of these targets. One mRNA target that was validated is the MDV-1 mRNA encoding the viral RLORF8 protein, which lies antisense to no fewer than four MDV-1 miRNAs in the MDV-1 genome. As predicted by this location, we observed the most intense RISC binding clusters detected on the MDV-1 genome at the location of the RLORF8 transcript (<xref ref-type="fig" rid="fig3">Fig.&#x000a0;3A</xref>) and analysis of indicator constructs in cotransfected 293T cells (<xref ref-type="fig" rid="fig4">Fig.&#x000a0;4A</xref>) or transduced MSB1 cells (<xref ref-type="fig" rid="fig4">Fig.&#x000a0;4B</xref>) confirmed that RLORF8 is indeed targeted by all four of these MDV-1 miRNAs. Interestingly, expression of the MDV-1 RLORF8 gene in a form lacking the viral miRNA binding sites caused a substantial reduction in MSB1 cell growth (<xref ref-type="fig" rid="fig4">Fig.&#x000a0;4C</xref>), consistent with the idea that dysregulated expression of RLORF8 can exert a deleterious effect in MDV-1-infected T cells. However, the function of RLORF8 in the viral life cycle is currently unknown, and we do not yet know why overexpression inhibits the growth of MDV-infected cells. The same pattern is observed in MDV-2, where five viral miRNAs are transcribed from the DNA strand located antisense to RLORF2 (<xref ref-type="fig" rid="fig3">Fig.&#x000a0;3B</xref>). Of note, the RLORF2 and RLORF8 proteins do not share significant amino acid sequence homology, and we were also unable to detect any significant homology between these two MDV proteins and proteins encoded by other herpesvirus species. Nevertheless, it remains possible that MDV-1 RLORF8 and MDV-2 RLORF2 do have similar functions. Targeting of MDV-1 genes by MDV-1-encoded miRNAs is not restricted to miRNAs transcribed from the antisense strand, as MDV1-M7-5p was previously shown to downregulate the MDV-1 immediate early genes ICP-4 and ICP-27 (<xref rid="B43" ref-type="bibr">43</xref>). Interestingly, in the human &#x003b1;-herpesvirus HSV-1, viral miRNAs are transcribed antisense to ICP0, a viral immediate-early gene, and ICP34.5, a late gene, and downregulate the expression of these genes (<xref rid="B8" ref-type="bibr">8</xref>, <xref rid="B37" ref-type="bibr">37</xref>). Although the physiological relevance of the regulation of viral transcripts by viral miRNAs is not currently clear, it is possible that downregulation of viral early genes helps to maintain the latent phase, while the targeting of the late genes contributes to maintaining the regulated expression of immediate early, early, and late genes upon lytic infection.</p><p>Analysis of cellular mRNAs targeted by MDV-1 and/or MDV-2 mRNAs identified several that were targeted by five or more different viral miRNAs in their 3&#x02032; UTRs (see <xref ref-type="supplementary-material" rid="tabS2">Table&#x000a0;S2</xref> in the supplemental material), suggestive of a possibly important role in restricting innate antiviral immunity. One factor that is expressed from an mRNA containing as many as seven viral miRNA target sites in its 3&#x02032; UTR is the chicken IL-18 gene. IL-18 is a proinflammatory cytokine that is induced upon infection by several different viruses and stimulates IFN-&#x003b3; production from T cells (<xref rid="B40" ref-type="bibr">40</xref>). As the MSB1 cell line is of T-cell origin, we were interested in whether ectopic expression of IL-18 would indeed result in reduced cell growth. In fact, MSB1 cell growth proved to be highly sensitive to inhibition by ectopic IL-18 expression, though it remains to be determined whether this is indeed due to induction of chicken IFN-&#x003b3; expression (<xref ref-type="fig" rid="fig5">Fig.&#x000a0;5</xref>). Thus, our data expose a second way in which MDV manipulates the host cell immune response, in addition to expressing a viral interleukin-8 (vIL-8) protein that is required for disease&#x000a0;progression and tumor development (<xref rid="B44" ref-type="bibr">44</xref>, <xref rid="B45" ref-type="bibr">45</xref>).</p><p>As noted above, we were particularly interested in identifying chicken mRNAs targeted by MDV-1 miR-M4, and PAR-CLIP indeed resulted in the identification of 73 mRNA 3&#x02032; UTR targets for miR-M4, of which 9 had previously been identified as targets for miR-155 or KSHV miR-K11 in EBV-transformed human B cells and KSHV-transformed human B cells, respectively (see <xref ref-type="supplementary-material" rid="tabS3">Table&#x000a0;S3</xref> in the supplemental material). Indicator analysis of these 3&#x02032; UTRs, several of which have previously been validated as miR-K11 or miR-155 targets, gave data consistent with the hypothesis that these mRNAs are indeed targets for both miR-M4 in MSB1 and miR-155 in human B-cell lymphomas. Particularly interesting shared gene targets for miR-155/miR-M4/miR-K11 include JARID2, a histone methyltransferase and a known target for miR-155 in avian cells that has been shown to promote apoptosis and decrease cell survival when ectopically expressed (<xref rid="B46" ref-type="bibr">46</xref>), and LATS (large tumor suppressor), a protein kinase component of the Hippo pathway that inhibits YAP transcriptional activity and therefore both inhibits cell proliferation and promotes apoptosis. LATS sequence and function is evolutionarily conserved from avians to mammals and its loss is observed in many human cancers, including acute lymphoblastic leukemia (<xref rid="B47" ref-type="bibr">47</xref>). These activities suggest a potential selective advantage for MDV-1 in inducing downregulation of LATS. Another interesting miR-155/miR-M4/miR-K11 target, NF-&#x003ba;B-inducing kinase (MAP3K14/NIK), was reported to be an important regulator of the noncanonical NF-&#x003ba;B pathway (<xref rid="B48" ref-type="bibr">48</xref>). NIK is important for the development of both B cells and T cells (<xref rid="B49" ref-type="bibr">49</xref><xref ref-type="bibr" rid="B50">&#x02013;</xref><xref rid="B51" ref-type="bibr">51</xref>) and may also have the potential to inhibit viral replication. It will therefore be of interest to test whether knockdown of these mRNAs using siRNAs can compensate for the previously reported loss of cell growth seen in EBV-transformed human B cells upon inhibition of miR-155 expression (<xref rid="B26" ref-type="bibr">26</xref>).</p></sec><sec sec-type="materials|methods" id="h3"><title>MATERIALS AND METHODS</title><sec id="h3.1"><title>Small RNA libraries and PAR-CLIP.</title><p>Small RNA and PAR-CLIP libraries were constructed as previously described (<xref rid="B32" ref-type="bibr">32</xref>, <xref rid="B52" ref-type="bibr">52</xref>). A 3-ml MSB1 cell pellet was used for PAR-CLIP, and the RISC pull-down was performed with a pan-Ago antibody (Abcam: AB 57113) that also recognizes chicken Ago proteins (data not shown). The resulting reads were pre-processed using the FASTX-Toolkit (<uri xlink:type="simple" xlink:href="http://www.sciencedirect.com/science?_ob=RedirectURL&#x00026;_method=externObjLink&#x00026;_locator=url&#x00026;_issn=19313128&#x00026;_origin=article&#x00026;_zone=art_page&#x00026;_plusSign=%2B&#x00026;_targetURL=http%253A%252F%252Fhannonlab.cshl.edu%252Ffastx_toolkit%252F">http://hannonlab.cshl.edu/fastx_toolkit/</uri>). Reads longer than 15&#x000a0;nt were aligned to the chicken (Gallus_gallus-4.0 ENSEMBLE), MDV-1 (GenBank accession no. AF243438.1) or MDV-2 (GenBank accession no. AB049735.1) genome using Bowtie (<xref rid="B53" ref-type="bibr">53</xref>). One mismatch was allowed in the small RNA library alignments and three in the PAR-CLIP library alignments.</p><p>For the analysis of PAR-CLIP data, we used PARalyzer version 1.1 (<xref rid="B34" ref-type="bibr">34</xref>) with the following parameters: a minimum cluster read depth of 15 and at least 2&#x000a0;T-to-C conversion locations were required. miRNA assignments to each cluster, based on the small RNA libraries, were designated according to standard nomenclature (<xref rid="B1" ref-type="bibr">1</xref>) with a minimal seed match of &#x0201c;7mer1A.&#x0201d; Human orthologs of chicken genes were assigned based on ENSEMBLE annotation. In order to avoid possible misannotation of the chicken genome, we included in our annotation 500&#x000a0;bp downstream of the predicted 3&#x02032; UTR, as detailed in <xref ref-type="supplementary-material" rid="tabS1">Table&#x000a0;S1</xref> in the supplemental material. The data reported in this paper include this extension as part of the 3&#x02032; UTR. In order to generate <xref ref-type="fig" rid="fig3">Fig.&#x000a0;3</xref>, we used the Integrative Genomics Viewer (IGV) (<xref rid="B54" ref-type="bibr">54</xref>, <xref rid="B55" ref-type="bibr">55</xref>).</p></sec><sec id="h3.2"><title>Cell culture and transduction.</title><p>MSB1 cells (a gift from Hsiao-Ching Liu) were grown in RPMI 1640 supplemented with penicillin, 10% fetal bovine serum (FBS), 10% tryptose phosphate broth, and 1% sodium pyruvate at 37&#x000b0;C.&#x000a0;293T cells were grown in Dulbecco&#x02019;s modified Eagle medium (Sigma) supplemented with 10% FBS.</p><p>Packaging of pGIPZ or pL-CMV-GL3-derived lentiviral vectors was performed in 293T cells using pMDLgpRRE, pRSV-Rev, and pVSV-G (<xref rid="B56" ref-type="bibr">56</xref>). pTRIPZ-derived lentiviral vectors were packaged using pCMV&#x00394;R8.75 and pMD2G. These plasmids were cotransfected into 293T cells (10-cm plate) using calcium phosphate, and virus was collected after 48 and 72&#x000a0;h to infect 1.5 &#x000d7; 10<sup>6</sup> MSB1 cells in 6-well plates. Cells were grown for 3&#x000a0;days before selection using puromycin.</p></sec><sec id="h3.3"><title>Growth curves.</title><p>Newly transduced MSB1 cells were grown in the presence of puromycin (Sigma) at a final concentration of 1&#x000a0;&#x000b5;g/ml for 14&#x000a0;days to select transductants. Doxycycline (Sigma) at a final concentration of 1&#x000a0;&#x000b5;g/ml was used to induce expression for 3 to 5&#x000a0;days before the initiation of each growth experiment, when MSB1 cells were diluted to 4 &#x000d7; 10<sup>5</sup>&#x000a0;cells/ml. The cells were split into conditioned media several times during the experiment, when the cell concentration exceeded 8 &#x000d7; 10<sup>5</sup>&#x000a0;cells/ml. Cells were counted using FACSCanto and FlowJo software.</p></sec><sec id="h3.4"><title>Primer extension.</title><p>Total RNA from 293T cells and MSB1 cells was prepared using TRIzol (Invitrogen). Primer extension was performed using 8&#x000a0;&#x000b5;g of total RNA using an avian myeloblastosis virus primer extension kit (Promega), according to the manufacturer&#x02019;s protocol. Reaction products were analyzed on 15% Tris-borate-EDTA-urea polyacrylamide gels.</p></sec><sec id="h3.5"><title>Plasmids.</title><p>DNA fragments containing the pri-miRNA stem-loops of MDV-1 miR-M2, miR-M3, miR-M4, and miR-M12, as well as up to 150&#x000a0;bp of viral genomic flanking sequences, were PCR amplified from total DNA purified from MSB1 cells, using primers listed in <xref ref-type="supplementary-material" rid="tabS4">Table&#x000a0;S4</xref> in the supplemental material. These DNA fragments were then cloned into the previously described pLCE vector (<xref rid="B57" ref-type="bibr">57</xref>) using XhoI and EcoRI. For each of the four miRNAs, we cloned two perfect targets into the XhoI and XbaI sites present in the <italic>fluc</italic>-based indicator pL-CMV-GL3 (<xref rid="B58" ref-type="bibr">58</xref>) by annealing two long complementary primers (see <xref ref-type="supplementary-material" rid="tabS4">Table&#x000a0;S4</xref>). The miR-155 expression plasmid and the indicator plasmid containing perfect targets for miR-155 were described previously (<xref rid="B20" ref-type="bibr">20</xref>).</p><p>Chicken genes targeted by MDV1 miR-M4 and human miR-155 were cloned into the XhoI and EcoRI sites present in the <italic>fluc</italic> indicator vector pL-CMV-GL3 using primers listed in <xref ref-type="supplementary-material" rid="tabS4">Table&#x000a0;S4</xref> in the supplemental material. These DNA fragments include part of the 500-bp 3&#x02032; UTR extension in relevant cases. All forward primers contained an XhoI site, while reverse primers contained an EcoRI site. Primers were chosen using the IDT PrimerQuest website. In order to create mutations in the predicted binding sites of MDV1-miR-M4, the six nucleotides that align to the miR-M4 seed region (nt 2 to 7) in the 3&#x02032; UTRs of RORA, RPS, WEE1, CSNK, and JARID2 were replaced with an Spe1 restriction site (5&#x02032;&#x000a0;ATCATG&#x000a0;3&#x02032;). The sequence 5&#x02032;&#x000a0;CTTA&#x000a0;3&#x02032; in the 3&#x02032; UTRs of LATS and Orf103 was replaced with 5&#x02032;&#x000a0;TAGG&#x000a0;3&#x02032;. The MYB 3&#x02032; UTR was cloned twice, first with a 5&#x02032; primer starting at the beginning of the 3&#x02032; UTR and second with a primer that starts 40&#x000a0;bp downstream of the 3&#x02032; UTR start site and does not contain the predicted MDV1 miR-M4 target site.</p><p>An ~820&#x000a0;bp DNA fragment containing RLORF8 and its 3&#x02032; UTR were cloned into pL-CMV-GL3 using XhoI and EcoRI. Mutations in the predicted miRNA binding sites in the coding and 3&#x02032; UTR regions of RLORF8 were generated with primers listed in <xref ref-type="supplementary-material" rid="tabS4">Table&#x000a0;S4</xref> in the supplemental material. These mutations modify part of the seed binding site and part of the region 3&#x02032; of the binding site in order to prevent the formation of a stem-loop that may be generated from an internal promoter on the minus strand. The pGIPZ vector used in this study contains GFP instead of RFP and is based on pTRIPZ (Open Biosystems), as previously described (<xref rid="B58" ref-type="bibr">58</xref>).</p><p>For the growth experiment whose results are shown in <xref ref-type="fig" rid="fig4">Fig.&#x000a0;4C</xref>, the RLORF8 open reading frame, including the stop codon, was cloned into pGIPZ in place of <italic>gfp</italic> using AgeI and EcoRI. The introduced mutations in the predicted seed binding sites of MDV-1 miR-M2 and miR-M4 in the RLORF8 ORF preserved the original amino acid sequence. The chicken IL-18 open reading frame was cloned without the 3&#x02032; UTR or with the 3&#x02032; UTR, including a 500-bp extension, into pGIPZ in place of the <italic>gfp</italic> gene using AgeI and EcoRI.</p></sec><sec id="h3.6"><title>Luciferase indicator assays.</title><p>293T cells were plated in 24-well plates at 10<sup>5</sup> cells per well. Cotransfection of 500&#x000a0;ng of a pLCE-based miRNA expression vector, 20&#x000a0;ng of a pL-CMV-GL3-based <italic>fluc</italic> indicator plasmid and 20&#x000a0;ng of the pL-CMV-Rluc (<xref rid="B58" ref-type="bibr">58</xref>) internal control was performed using calcium phosphate. At 72&#x000a0;h posttransfection, cells were lysed in passive lysis buffer, and RLuc and FLuc activities were measured using a dual-luciferase reporter assay system (Promega), according to the manufacturer&#x02019;s instructions. The ratio between the Fluc and internal control Rluc proteins was then determined for each sample. In the experiment whose results are shown in <xref ref-type="fig" rid="fig4">Fig.&#x000a0;4B</xref>, MSB1 and DT40 cells were transduced with equal amounts of the pL-CMV-GL3-based lentiviral vector for 72&#x000a0;h prior to analysis.</p></sec><sec id="h3.7"><title>Sequence data accession number.</title><p>Sequencing data have been submitted to the NCBI Sequence Read Archive (SRA) (GEO accession number GSE53806). Processed files will be made available upon request.</p></sec></sec><sec sec-type="supplementary-material" id="h4"><title>SUPPLEMENTAL MATERIAL</title><supplementary-material id="tabS1"><label>Table&#x000a0;S1</label><caption><p>List of all PAR-CLIP clusters found in MSB1 cells. </p></caption><media xlink:href="mbo001141718st1.xlsx"><caption><p>Table&#x000a0;S1, XLSX file, 2.8 MB.</p></caption></media></supplementary-material>
<supplementary-material id="tabS2"><label>Table&#x000a0;S2</label><caption><p>List of chicken genes that contain a 3&#x02032; UTR found to bind 5 or more viral miRNAs in MSB1 cells, as determined by PAR-CLIP analysis. </p></caption><media xlink:href="mbo001141718st2.xlsx"><caption><p>Table&#x000a0;S2, XLSX file, 0.1 MB.</p></caption></media></supplementary-material>
<supplementary-material id="tabS3"><label>Table&#x000a0;S3</label><caption><p>List of all PAR-CLIP-detected MDV-1 miR-M4 mRNA binding sites found in this study in MSB1 cells. </p></caption><media xlink:href="mbo001141718st3.pdf"><caption><p>Table&#x000a0;S3, PDF file, 0.1 MB.</p></caption></media></supplementary-material>
<supplementary-material id="tabS4"><label>Table&#x000a0;S4</label><caption><p>List of all DNA primers used in this study. </p></caption><media xlink:href="mbo001141718st4.pdf"><caption><p>Table&#x000a0;S4, PDF file, 0.2 MB.</p></caption></media></supplementary-material>
</sec></body><back><fn-group><fn fn-type="other"><p><bold>Citation</bold> Parnas O, Corcoran DL, Cullen Bryan R. 2014. Analysis of the mRNA targetome of microRNAs expressed by Marek&#x02019;s disease virus. mBio 5(1):e01060-13. doi:10.1128/mBio.01060-13.</p></fn></fn-group><ack><title>ACKNOWLEDGMENTS</title><p>We thank Chris Pierick and Joy Marshall for their help in DNA cloning, Rebecca Skalsky for helpful discussions, and Jianghai Ho for technical assistance. We thank the Duke Flow Core for assistance with fluorescence-activated cell sorting and the members of the IGSP Duke Sequencing Core for cDNA deep sequencing. We thank Hsiao-Ching Liu (NC State University) for the MSB1 cells used in this analysis.</p><p>This research was funded by <funding-source id="GS1">NIH</funding-source> grant <award-id rid="GS1">R01-AI067968</award-id> to B.R.C. and by European Molecular Biology Organization fellowship EMBO <award-id id="G1">ALTF 1515-2011</award-id> to O.P. </p></ack><ref-list><title>REFERENCES</title><ref id="B1"><label>1.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bartel</surname><given-names>DP</given-names></name></person-group>
<year>2009</year>
<article-title>MicroRNAs: target recognition and regulatory functions</article-title>. <source>Cell</source>
<volume>136</volume>:<fpage>215</fpage>&#x02013;<lpage>233</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2009.01.002</pub-id><pub-id pub-id-type="pmid">19167326</pub-id></mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cullen</surname><given-names>BR</given-names></name></person-group>
<year>2004</year>
<article-title>Transcription and processing of human microRNA precursors</article-title>. <source>Mol. Cell</source>
<volume>16</volume>:<fpage>861</fpage>&#x02013;<lpage>865</lpage>. <pub-id pub-id-type="doi">10.1016/j.molcel.2004.12.002</pub-id><pub-id pub-id-type="pmid">15610730</pub-id></mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yi</surname><given-names>R</given-names></name><name><surname>Qin</surname><given-names>Y</given-names></name><name><surname>Macara</surname><given-names>IG</given-names></name><name><surname>Cullen</surname><given-names>BR</given-names></name></person-group>
<year>2003</year>
<article-title>Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs</article-title>. <source>Genes Dev.</source>
<volume>17</volume>:<fpage>3011</fpage>&#x02013;<lpage>3016</lpage>. <pub-id pub-id-type="doi">10.1101/gad.1158803</pub-id><pub-id pub-id-type="pmid">14681208</pub-id></mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chendrimada</surname><given-names>TP</given-names></name><name><surname>Gregory</surname><given-names>RI</given-names></name><name><surname>Kumaraswamy</surname><given-names>E</given-names></name><name><surname>Norman</surname><given-names>J</given-names></name><name><surname>Cooch</surname><given-names>N</given-names></name><name><surname>Nishikura</surname><given-names>K</given-names></name><name><surname>Shiekhattar</surname><given-names>R</given-names></name></person-group>
<year>2005</year>
<article-title>TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing</article-title>. <source>Nature</source>
<volume>436</volume>:<fpage>740</fpage>&#x02013;<lpage>744</lpage>. <pub-id pub-id-type="doi">10.1038/nature03868</pub-id><pub-id pub-id-type="pmid">15973356</pub-id></mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Khvorova</surname><given-names>A</given-names></name><name><surname>Reynolds</surname><given-names>A</given-names></name><name><surname>Jayasena</surname><given-names>SD</given-names></name></person-group>
<year>2003</year>
<article-title>Functional siRNAs and miRNAs exhibit strand bias</article-title>. <source>Cell</source>
<volume>115</volume>:<fpage>209</fpage>&#x02013;<lpage>216</lpage>. <pub-id pub-id-type="doi">10.1016/S0092-8674(03)00801-8</pub-id><pub-id pub-id-type="pmid">14567918</pub-id></mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cullen</surname><given-names>BR</given-names></name></person-group>
<year>2013</year>
<article-title>MicroRNAs as mediators of viral evasion of the immune system</article-title>. <source>Nat. Immunol.</source>
<volume>14</volume>:<fpage>205</fpage>&#x02013;<lpage>210</lpage>. <pub-id pub-id-type="doi">10.1038/ni.2537</pub-id><pub-id pub-id-type="pmid">23416678</pub-id></mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Grundhoff</surname><given-names>A</given-names></name><name><surname>Sullivan</surname><given-names>CS</given-names></name></person-group>
<year>2011</year>
<article-title>Virus-encoded microRNAs</article-title>. <source>Virology</source>
<volume>411</volume>:<fpage>325</fpage>&#x02013;<lpage>343</lpage>. <pub-id pub-id-type="doi">10.1016/j.virol.2011.01.002</pub-id><pub-id pub-id-type="pmid">21277611</pub-id></mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Umbach</surname><given-names>JL</given-names></name><name><surname>Kramer</surname><given-names>MF</given-names></name><name><surname>Jurak</surname><given-names>I</given-names></name><name><surname>Karnowski</surname><given-names>HW</given-names></name><name><surname>Coen</surname><given-names>DM</given-names></name><name><surname>Cullen</surname><given-names>BR</given-names></name></person-group>
<year>2008</year>
<article-title>MicroRNAs expressed by herpes simplex virus 1 during latent infection regulate viral mRNAs</article-title>. <source>Nature</source>
<volume>454</volume>:<fpage>780</fpage>&#x02013;<lpage>783</lpage>. <pub-id pub-id-type="doi">10.1038/nature07103</pub-id><pub-id pub-id-type="pmid">18596690</pub-id></mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Boss</surname><given-names>IW</given-names></name><name><surname>Renne</surname><given-names>R</given-names></name></person-group>
<year>2011</year>
<article-title>Viral miRNAs and immune evasion</article-title>. <source>Biochim. Biophys. Acta</source>
<volume>1809</volume>:<fpage>708</fpage>&#x02013;<lpage>714</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbagrm.2011.06.012</pub-id><pub-id pub-id-type="pmid">21757042</pub-id></mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Osterrieder</surname><given-names>N</given-names></name><name><surname>Kamil</surname><given-names>JP</given-names></name><name><surname>Schumacher</surname><given-names>D</given-names></name><name><surname>Tischer</surname><given-names>BK</given-names></name><name><surname>Trapp</surname><given-names>S</given-names></name></person-group>
<year>2006</year>
<article-title>Marek&#x02019;s disease virus: from miasma to model</article-title>. <source>Nat. Rev. Microbiol.</source>
<volume>4</volume>:<fpage>283</fpage>&#x02013;<lpage>294</lpage>. <pub-id pub-id-type="doi">10.1038/nrmicro1382</pub-id><pub-id pub-id-type="pmid">16541136</pub-id></mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nair</surname><given-names>V</given-names></name></person-group>
<year>2005</year>
<article-title>Evolution of Marek&#x02019;s disease&#x02014;a paradigm for incessant race between the pathogen and the host</article-title>. <source>Vet. J.</source>
<volume>170</volume>:<fpage>175</fpage>&#x02013;<lpage>183</lpage>. <pub-id pub-id-type="doi">10.1016/j.tvjl.2004.05.009</pub-id><pub-id pub-id-type="pmid">16129338</pub-id></mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mwangi</surname><given-names>WN</given-names></name><name><surname>Smith</surname><given-names>LP</given-names></name><name><surname>Baigent</surname><given-names>SJ</given-names></name><name><surname>Beal</surname><given-names>RK</given-names></name><name><surname>Nair</surname><given-names>V</given-names></name><name><surname>Smith</surname><given-names>AL</given-names></name></person-group>
<year>2011</year>
<article-title>Clonal structure of rapid-onset MDV-driven CD4+ lymphomas and responding CD8+ T cells</article-title>. <source>PLoS Pathog.</source>
<volume>7</volume>:<fpage>e1001337</fpage>. <pub-id pub-id-type="doi">10.1371/journal.ppat.1001337</pub-id><pub-id pub-id-type="pmid">21573129</pub-id></mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Burnside</surname><given-names>J</given-names></name><name><surname>Bernberg</surname><given-names>E</given-names></name><name><surname>Anderson</surname><given-names>A</given-names></name><name><surname>Lu</surname><given-names>C</given-names></name><name><surname>Meyers</surname><given-names>BC</given-names></name><name><surname>Green</surname><given-names>PJ</given-names></name><name><surname>Jain</surname><given-names>N</given-names></name><name><surname>Isaacs</surname><given-names>G</given-names></name><name><surname>Morgan</surname><given-names>RW</given-names></name></person-group>
<year>2006</year>
<article-title>Marek&#x02019;s disease virus encodes microRNAs that map to meq and the latency-associated transcript</article-title>. <source>J. Virol.</source>
<volume>80</volume>:<fpage>8778</fpage>&#x02013;<lpage>8786</lpage>. <pub-id pub-id-type="doi">10.1128/JVI.00831-06</pub-id><pub-id pub-id-type="pmid">16912324</pub-id></mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yao</surname><given-names>Y</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Xu</surname><given-names>H</given-names></name><name><surname>Smith</surname><given-names>LP</given-names></name><name><surname>Lawrie</surname><given-names>CH</given-names></name><name><surname>Sewer</surname><given-names>A</given-names></name><name><surname>Zavolan</surname><given-names>M</given-names></name><name><surname>Nair</surname><given-names>V</given-names></name></person-group>
<year>2007</year>
<article-title>Marek&#x02019;s disease virus type 2 (MDV-2)-encoded microRNAs show no sequence conservation with those encoded by MDV-1</article-title>. <source>J. Virol.</source>
<volume>81</volume>:<fpage>7164</fpage>&#x02013;<lpage>7170</lpage>. <pub-id pub-id-type="doi">10.1128/JVI.00112-07</pub-id><pub-id pub-id-type="pmid">17459919</pub-id></mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yao</surname><given-names>Y</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Xu</surname><given-names>H</given-names></name><name><surname>Smith</surname><given-names>LP</given-names></name><name><surname>Lawrie</surname><given-names>CH</given-names></name><name><surname>Watson</surname><given-names>M</given-names></name><name><surname>Nair</surname><given-names>V</given-names></name></person-group>
<year>2008</year>
<article-title>MicroRNA profile of Marek&#x02019;s disease virus-transformed T-cell line MSB-1: predominance of virus-encoded microRNAs</article-title>. <source>J. Virol.</source>
<volume>82</volume>:<fpage>4007</fpage>&#x02013;<lpage>4015</lpage>. <pub-id pub-id-type="doi">10.1128/JVI.02659-07</pub-id><pub-id pub-id-type="pmid">18256158</pub-id></mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Waidner</surname><given-names>LA</given-names></name><name><surname>Morgan</surname><given-names>RW</given-names></name><name><surname>Anderson</surname><given-names>AS</given-names></name><name><surname>Bernberg</surname><given-names>EL</given-names></name><name><surname>Kamboj</surname><given-names>S</given-names></name><name><surname>Garcia</surname><given-names>M</given-names></name><name><surname>Riblet</surname><given-names>SM</given-names></name><name><surname>Ouyang</surname><given-names>M</given-names></name><name><surname>Isaacs</surname><given-names>GK</given-names></name><name><surname>Markis</surname><given-names>M</given-names></name><name><surname>Meyers</surname><given-names>BC</given-names></name><name><surname>Green</surname><given-names>PJ</given-names></name><name><surname>Burnside</surname><given-names>J</given-names></name></person-group>
<year>2009</year>
<article-title>MicroRNAs of gallid and meleagrid herpesviruses show generally conserved genomic locations and are virus-specific</article-title>. <source>Virology</source>
<volume>388</volume>:<fpage>128</fpage>&#x02013;<lpage>136</lpage>. <pub-id pub-id-type="doi">10.1016/j.virol.2009.02.043</pub-id><pub-id pub-id-type="pmid">19328516</pub-id></mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Morgan</surname><given-names>R</given-names></name><name><surname>Anderson</surname><given-names>A</given-names></name><name><surname>Bernberg</surname><given-names>E</given-names></name><name><surname>Kamboj</surname><given-names>S</given-names></name><name><surname>Huang</surname><given-names>E</given-names></name><name><surname>Lagasse</surname><given-names>G</given-names></name><name><surname>Isaacs</surname><given-names>G</given-names></name><name><surname>Parcells</surname><given-names>M</given-names></name><name><surname>Meyers</surname><given-names>BC</given-names></name><name><surname>Green</surname><given-names>PJ</given-names></name><name><surname>Burnside</surname><given-names>J</given-names></name></person-group>
<year>2008</year>
<article-title>Sequence conservation and differential expression of Marek&#x02019;s disease virus microRNAs</article-title>. <source>J. Virol.</source>
<volume>82</volume>:<fpage>12213</fpage>&#x02013;<lpage>12220</lpage>. <pub-id pub-id-type="doi">10.1128/JVI.01722-08</pub-id><pub-id pub-id-type="pmid">18842708</pub-id></mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Morgan</surname><given-names>RW</given-names></name><name><surname>Burnside</surname><given-names>J</given-names></name></person-group>
<year>2011</year>
<article-title>Roles of avian herpesvirus microRNAs in infection, latency, and oncogenesis</article-title>. <source>Biochim. Biophys. Acta</source>
<volume>1809</volume>:<fpage>654</fpage>&#x02013;<lpage>659</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbagrm.2011.06.001</pub-id><pub-id pub-id-type="pmid">21683170</pub-id></mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Yao</surname><given-names>Y</given-names></name><name><surname>Xu</surname><given-names>H</given-names></name><name><surname>Lambeth</surname><given-names>L</given-names></name><name><surname>Smith</surname><given-names>LP</given-names></name><name><surname>Kgosana</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Nair</surname><given-names>V</given-names></name></person-group>
<year>2009</year>
<article-title>A functional microRNA-155 ortholog encoded by the oncogenic Marek&#x02019;s disease virus</article-title>. <source>J. Virol.</source>
<volume>83</volume>:<fpage>489</fpage>&#x02013;<lpage>492</lpage>. <pub-id pub-id-type="doi">10.1128/JVI.01166-08</pub-id><pub-id pub-id-type="pmid">18945769</pub-id></mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gottwein</surname><given-names>E</given-names></name><name><surname>Mukherjee</surname><given-names>N</given-names></name><name><surname>Sachse</surname><given-names>C</given-names></name><name><surname>Frenzel</surname><given-names>C</given-names></name><name><surname>Majoros</surname><given-names>WH</given-names></name><name><surname>Chi</surname><given-names>JT</given-names></name><name><surname>Braich</surname><given-names>R</given-names></name><name><surname>Manoharan</surname><given-names>M</given-names></name><name><surname>Soutschek</surname><given-names>J</given-names></name><name><surname>Ohler</surname><given-names>U</given-names></name><name><surname>Cullen</surname><given-names>BR</given-names></name></person-group>
<year>2007</year>
<article-title>A viral microRNA functions as an orthologue of cellular miR-155</article-title>. <source>Nature</source>
<volume>450</volume>:<fpage>1096</fpage>&#x02013;<lpage>1099</lpage>. <pub-id pub-id-type="doi">10.1038/nature05992</pub-id><pub-id pub-id-type="pmid">18075594</pub-id></mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Skalsky</surname><given-names>RL</given-names></name><name><surname>Samols</surname><given-names>MA</given-names></name><name><surname>Plaisance</surname><given-names>KB</given-names></name><name><surname>Boss</surname><given-names>IW</given-names></name><name><surname>Riva</surname><given-names>A</given-names></name><name><surname>Lopez</surname><given-names>MC</given-names></name><name><surname>Baker</surname><given-names>HV</given-names></name><name><surname>Renne</surname><given-names>R</given-names></name></person-group>
<year>2007</year>
<article-title>Kaposi&#x02019;s sarcoma-associated herpesvirus encodes an ortholog of miR-155</article-title>. <source>J. Virol.</source>
<volume>81</volume>:<fpage>12836</fpage>&#x02013;<lpage>12845</lpage>. <pub-id pub-id-type="doi">10.1128/JVI.01804-07</pub-id><pub-id pub-id-type="pmid">17881434</pub-id></mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Boss</surname><given-names>IW</given-names></name><name><surname>Nadeau</surname><given-names>PE</given-names></name><name><surname>Abbott</surname><given-names>JR</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Mergia</surname><given-names>A</given-names></name><name><surname>Renne</surname><given-names>R</given-names></name></person-group>
<year>2011</year>
<article-title>A Kaposi&#x02019;s sarcoma-associated herpesvirus-encoded ortholog of microRNA miR-155 induces human splenic B-cell expansion in NOD/LtSz-scid IL2R&#x003b3;null mice</article-title>. <source>J. Virol.</source>
<volume>85</volume>:<fpage>9877</fpage>&#x02013;<lpage>9886</lpage>. <pub-id pub-id-type="doi">10.1128/JVI.05558-11</pub-id><pub-id pub-id-type="pmid">21813606</pub-id></mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sin</surname><given-names>SH</given-names></name><name><surname>Kim</surname><given-names>YB</given-names></name><name><surname>Dittmer</surname><given-names>DP</given-names></name></person-group>
<year>2013</year>
<article-title>Latency locus complements microRNA 155 deficiency in vivo</article-title>. <source>J. Virol.</source>
<volume>87</volume>:<fpage>11908</fpage>&#x02013;<lpage>11911</lpage>. <pub-id pub-id-type="doi">10.1128/JVI.01620-13</pub-id><pub-id pub-id-type="pmid">23966392</pub-id></mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Costinean</surname><given-names>S</given-names></name><name><surname>Zanesi</surname><given-names>N</given-names></name><name><surname>Pekarsky</surname><given-names>Y</given-names></name><name><surname>Tili</surname><given-names>E</given-names></name><name><surname>Volinia</surname><given-names>S</given-names></name><name><surname>Heerema</surname><given-names>N</given-names></name><name><surname>Croce</surname><given-names>CM</given-names></name></person-group>
<year>2006</year>
<article-title>Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E(mu)-miR155 transgenic mice</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A.</source>
<volume>103</volume>:<fpage>7024</fpage>&#x02013;<lpage>7029</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0602266103</pub-id><pub-id pub-id-type="pmid">16641092</pub-id></mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cameron</surname><given-names>JE</given-names></name><name><surname>Fewell</surname><given-names>C</given-names></name><name><surname>Yin</surname><given-names>Q</given-names></name><name><surname>McBride</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Lin</surname><given-names>Z</given-names></name><name><surname>Flemington</surname><given-names>EK</given-names></name></person-group>
<year>2008</year>
<article-title>Epstein-Barr virus growth/latency III program alters cellular microRNA expression</article-title>. <source>Virology</source>
<volume>382</volume>:<fpage>257</fpage>&#x02013;<lpage>266</lpage>. <pub-id pub-id-type="doi">10.1016/j.virol.2008.09.018</pub-id><pub-id pub-id-type="pmid">18950829</pub-id></mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Linnstaedt</surname><given-names>SD</given-names></name><name><surname>Gottwein</surname><given-names>E</given-names></name><name><surname>Skalsky</surname><given-names>RL</given-names></name><name><surname>Luftig</surname><given-names>MA</given-names></name><name><surname>Cullen</surname><given-names>BR</given-names></name></person-group>
<year>2010</year>
<article-title>Virally induced cellular microRNA miR-155 plays a key role in B-cell immortalization by Epstein-Barr virus</article-title>. <source>J. Virol.</source>
<volume>84</volume>:<fpage>11670</fpage>&#x02013;<lpage>11678</lpage>. <pub-id pub-id-type="doi">10.1128/JVI.01248-10</pub-id><pub-id pub-id-type="pmid">20844043</pub-id></mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Xu</surname><given-names>H</given-names></name><name><surname>Yao</surname><given-names>Y</given-names></name><name><surname>Smith</surname><given-names>LP</given-names></name><name><surname>Kgosana</surname><given-names>L</given-names></name><name><surname>Green</surname><given-names>J</given-names></name><name><surname>Petherbridge</surname><given-names>L</given-names></name><name><surname>Baigent</surname><given-names>SJ</given-names></name><name><surname>Nair</surname><given-names>V</given-names></name></person-group>
<year>2011</year>
<article-title>Critical role of the virus-encoded microRNA-155 ortholog in the induction of Marek&#x02019;s disease lymphomas</article-title>. <source>PLoS Pathog.</source>
<volume>7</volume>:<fpage>e1001305</fpage>. <pub-id pub-id-type="doi">10.1371/journal.ppat.1001305</pub-id><pub-id pub-id-type="pmid">21383974</pub-id></mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gottwein</surname><given-names>E</given-names></name><name><surname>Corcoran</surname><given-names>DL</given-names></name><name><surname>Mukherjee</surname><given-names>N</given-names></name><name><surname>Skalsky</surname><given-names>RL</given-names></name><name><surname>Hafner</surname><given-names>M</given-names></name><name><surname>Nusbaum</surname><given-names>JD</given-names></name><name><surname>Shamulailatpam</surname><given-names>P</given-names></name><name><surname>Love</surname><given-names>CL</given-names></name><name><surname>Dave</surname><given-names>SS</given-names></name><name><surname>Tuschl</surname><given-names>T</given-names></name><name><surname>Ohler</surname><given-names>U</given-names></name><name><surname>Cullen</surname><given-names>BR</given-names></name></person-group>
<year>2011</year>
<article-title>Viral microRNA targetome of KSHV-infected primary effusion lymphoma cell lines</article-title>. <source>Cell Host Microbe</source>
<volume>10</volume>:<fpage>515</fpage>&#x02013;<lpage>526</lpage>. <pub-id pub-id-type="doi">10.1016/j.chom.2011.09.012</pub-id><pub-id pub-id-type="pmid">22100165</pub-id></mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Skalsky</surname><given-names>RL</given-names></name><name><surname>Corcoran</surname><given-names>DL</given-names></name><name><surname>Gottwein</surname><given-names>E</given-names></name><name><surname>Frank</surname><given-names>CL</given-names></name><name><surname>Kang</surname><given-names>D</given-names></name><name><surname>Hafner</surname><given-names>M</given-names></name><name><surname>Nusbaum</surname><given-names>JD</given-names></name><name><surname>Feederle</surname><given-names>R</given-names></name><name><surname>Delecluse</surname><given-names>HJ</given-names></name><name><surname>Luftig</surname><given-names>MA</given-names></name><name><surname>Tuschl</surname><given-names>T</given-names></name><name><surname>Ohler</surname><given-names>U</given-names></name><name><surname>Cullen</surname><given-names>BR</given-names></name></person-group>
<year>2012</year>
<article-title>The viral and cellular microRNA targetome in lymphoblastoid cell lines</article-title>. <source>PLoS Pathog.</source>
<volume>8</volume>:<fpage>e1002484</fpage>. <pub-id pub-id-type="doi">10.1371/journal.ppat.1002484</pub-id><pub-id pub-id-type="pmid">22291592</pub-id></mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Haecker</surname><given-names>I</given-names></name><name><surname>Gay</surname><given-names>LA</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Hu</surname><given-names>J</given-names></name><name><surname>Morse</surname><given-names>AM</given-names></name><name><surname>McIntyre</surname><given-names>LM</given-names></name><name><surname>Renne</surname><given-names>R</given-names></name></person-group>
<year>2012</year>
<article-title>Ago HITS-CLIP expands understanding of Kaposi&#x02019;s sarcoma-associated herpesvirus miRNA function in primary effusion lymphomas</article-title>. <source>PLoS Pathog.</source>
<volume>8</volume>:<fpage>e1002884</fpage>. <pub-id pub-id-type="doi">10.1371/journal.ppat.1002884</pub-id><pub-id pub-id-type="pmid">22927820</pub-id></mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Riley</surname><given-names>KJ</given-names></name><name><surname>Rabinowitz</surname><given-names>GS</given-names></name><name><surname>Yario</surname><given-names>TA</given-names></name><name><surname>Luna</surname><given-names>JM</given-names></name><name><surname>Darnell</surname><given-names>RB</given-names></name><name><surname>Steitz</surname><given-names>JA</given-names></name></person-group>
<year>2012</year>
<article-title>EBV and human microRNAs co-target oncogenic and apoptotic viral and human genes during latency</article-title>. <source>EMBO J.</source>
<volume>31</volume>:<fpage>2207</fpage>&#x02013;<lpage>2221</lpage>. <pub-id pub-id-type="doi">10.1038/emboj.2012.63</pub-id><pub-id pub-id-type="pmid">22473208</pub-id></mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hafner</surname><given-names>M</given-names></name><name><surname>Landthaler</surname><given-names>M</given-names></name><name><surname>Burger</surname><given-names>L</given-names></name><name><surname>Khorshid</surname><given-names>M</given-names></name><name><surname>Hausser</surname><given-names>J</given-names></name><name><surname>Berninger</surname><given-names>P</given-names></name><name><surname>Rothballer</surname><given-names>A</given-names></name><name><surname>Ascano</surname><given-names>M</given-names><suffix>Jr</suffix></name><name><surname>Jungkamp</surname><given-names>AC</given-names></name><name><surname>Munschauer</surname><given-names>M</given-names></name><name><surname>Ulrich</surname><given-names>A</given-names></name><name><surname>Wardle</surname><given-names>GS</given-names></name><name><surname>Dewell</surname><given-names>S</given-names></name><name><surname>Zavolan</surname><given-names>M</given-names></name><name><surname>Tuschl</surname><given-names>T</given-names></name></person-group>
<year>2010</year>
<article-title>Transcriptome-wide identification of RNA-binding protein and microRNA target sites by PAR-CLIP</article-title>. <source>Cell</source>
<volume>141</volume>:<fpage>129</fpage>&#x02013;<lpage>141</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2010.03.009</pub-id><pub-id pub-id-type="pmid">20371350</pub-id></mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Licatalosi</surname><given-names>DD</given-names></name><name><surname>Mele</surname><given-names>A</given-names></name><name><surname>Fak</surname><given-names>JJ</given-names></name><name><surname>Ule</surname><given-names>J</given-names></name><name><surname>Kayikci</surname><given-names>M</given-names></name><name><surname>Chi</surname><given-names>SW</given-names></name><name><surname>Clark</surname><given-names>TA</given-names></name><name><surname>Schweitzer</surname><given-names>AC</given-names></name><name><surname>Blume</surname><given-names>JE</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Darnell</surname><given-names>JC</given-names></name><name><surname>Darnell</surname><given-names>RB</given-names></name></person-group>
<year>2008</year>
<article-title>HITS-CLIP yields genome-wide insights into brain alternative RNA processing</article-title>. <source>Nature</source>
<volume>456</volume>:<fpage>464</fpage>&#x02013;<lpage>469</lpage>. <pub-id pub-id-type="doi">10.1038/nature07488</pub-id><pub-id pub-id-type="pmid">18978773</pub-id></mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Corcoran</surname><given-names>DL</given-names></name><name><surname>Georgiev</surname><given-names>S</given-names></name><name><surname>Mukherjee</surname><given-names>N</given-names></name><name><surname>Gottwein</surname><given-names>E</given-names></name><name><surname>Skalsky</surname><given-names>RL</given-names></name><name><surname>Keene</surname><given-names>JD</given-names></name><name><surname>Ohler</surname><given-names>U</given-names></name></person-group>
<year>2011</year>
<article-title>PARalyzer: definition of RNA binding sites from PAR-CLIP short-read sequence data</article-title>. <source>Genome Biol.</source>
<volume>12</volume>:<fpage>R79</fpage>. <pub-id pub-id-type="doi">10.1186/gb-2011-12-8-r79</pub-id><pub-id pub-id-type="pmid">21851591</pub-id></mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hirai</surname><given-names>K</given-names></name><name><surname>Yamada</surname><given-names>M</given-names></name><name><surname>Arao</surname><given-names>Y</given-names></name><name><surname>Kato</surname><given-names>S</given-names></name><name><surname>Nii</surname><given-names>S</given-names></name></person-group>
<year>1990</year>
<article-title>Replicating Marek&#x02019;s disease virus (MDV) serotype 2 DNA with inserted MDV serotype 1 DNA sequences in a Marek&#x02019;s disease lymphoblastoid cell line MSB1-41C</article-title>. <source>Arch. Virol.</source>
<volume>114</volume>:<fpage>153</fpage>&#x02013;<lpage>165</lpage>. <pub-id pub-id-type="doi">10.1007/BF01310745</pub-id><pub-id pub-id-type="pmid">2173523</pub-id></mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chi</surname><given-names>SW</given-names></name><name><surname>Zang</surname><given-names>JB</given-names></name><name><surname>Mele</surname><given-names>A</given-names></name><name><surname>Darnell</surname><given-names>RB</given-names></name></person-group>
<year>2009</year>
<article-title>Argonaute HITS-CLIP decodes microRNA-mRNA interaction maps</article-title>. <source>Nature</source>
<volume>460</volume>:<fpage>479</fpage>&#x02013;<lpage>486</lpage><pub-id pub-id-type="pmid">19536157</pub-id></mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Flores</surname><given-names>O</given-names></name><name><surname>Nakayama</surname><given-names>S</given-names></name><name><surname>Whisnant</surname><given-names>AW</given-names></name><name><surname>Javanbakht</surname><given-names>H</given-names></name><name><surname>Cullen</surname><given-names>BR</given-names></name><name><surname>Bloom</surname><given-names>DC</given-names></name></person-group>
<year>2013</year>
<article-title>Mutational inactivation of herpes simplex virus 1 microRNAs identifies viral mRNA targets and reveals phenotypic effects in culture</article-title>. <source>J. Virol.</source>
<volume>87</volume>:<fpage>6589</fpage>&#x02013;<lpage>6603</lpage>. <pub-id pub-id-type="doi">10.1128/JVI.00504-13</pub-id><pub-id pub-id-type="pmid">23536669</pub-id></mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Okamura</surname><given-names>H</given-names></name><name><surname>Tsutsi</surname><given-names>H</given-names></name><name><surname>Komatsu</surname><given-names>T</given-names></name><name><surname>Yutsudo</surname><given-names>M</given-names></name><name><surname>Hakura</surname><given-names>A</given-names></name><name><surname>Tanimoto</surname><given-names>T</given-names></name><name><surname>Torigoe</surname><given-names>K</given-names></name><name><surname>Okura</surname><given-names>T</given-names></name><name><surname>Nukada</surname><given-names>Y</given-names></name><name><surname>Hattori</surname><given-names>K</given-names></name><etal/></person-group>
<year>1995</year>
<article-title>Cloning of a new cytokine that induces IFN-gamma production by T cells</article-title>. <source>Nature</source>
<volume>378</volume>:<fpage>88</fpage>&#x02013;<lpage>91</lpage>. <pub-id pub-id-type="doi">10.1038/378088a0</pub-id><pub-id pub-id-type="pmid">7477296</pub-id></mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ghayur</surname><given-names>T</given-names></name><name><surname>Banerjee</surname><given-names>S</given-names></name><name><surname>Hugunin</surname><given-names>M</given-names></name><name><surname>Butler</surname><given-names>D</given-names></name><name><surname>Herzog</surname><given-names>L</given-names></name><name><surname>Carter</surname><given-names>A</given-names></name><name><surname>Quintal</surname><given-names>L</given-names></name><name><surname>Sekut</surname><given-names>L</given-names></name><name><surname>Talanian</surname><given-names>R</given-names></name><name><surname>Paskind</surname><given-names>M</given-names></name><name><surname>Wong</surname><given-names>W</given-names></name><name><surname>Kamen</surname><given-names>R</given-names></name><name><surname>Tracey</surname><given-names>D</given-names></name><name><surname>Allen</surname><given-names>H</given-names></name></person-group>
<year>1997</year>
<article-title>Caspase-1 processes IFN-gamma-inducing factor and regulates LPS-induced IFN-gamma production</article-title>. <source>Nature</source>
<volume>386</volume>:<fpage>619</fpage>&#x02013;<lpage>623</lpage>. <pub-id pub-id-type="doi">10.1038/386619a0</pub-id><pub-id pub-id-type="pmid">9121587</pub-id></mixed-citation></ref><ref id="B40"><label>40.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kanneganti</surname><given-names>TD</given-names></name></person-group>
<year>2010</year>
<article-title>Central roles of NLRs and inflammasomes in viral infection</article-title>. <source>Nat. Rev. Immunol.</source>
<volume>10</volume>:<fpage>688</fpage>&#x02013;<lpage>698</lpage>. <pub-id pub-id-type="doi">10.1038/nri2851</pub-id><pub-id pub-id-type="pmid">20847744</pub-id></mixed-citation></ref><ref id="B41"><label>41.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wright</surname><given-names>GJ</given-names></name><name><surname>Puklavec</surname><given-names>MJ</given-names></name><name><surname>Willis</surname><given-names>AC</given-names></name><name><surname>Hoek</surname><given-names>RM</given-names></name><name><surname>Sedgwick</surname><given-names>JD</given-names></name><name><surname>Brown</surname><given-names>MH</given-names></name><name><surname>Barclay</surname><given-names>AN</given-names></name></person-group>
<year>2000</year>
<article-title>Lymphoid/neuronal cell surface OX2 glycoprotein recognizes a novel receptor on macrophages implicated in the control of their function</article-title>. <source>Immunity</source>
<volume>13</volume>:<fpage>233</fpage>&#x02013;<lpage>242</lpage>. <pub-id pub-id-type="doi">10.1016/S1074-7613(00)00023-6</pub-id><pub-id pub-id-type="pmid">10981966</pub-id></mixed-citation></ref><ref id="B42"><label>42.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Karnam</surname><given-names>G</given-names></name><name><surname>Rygiel</surname><given-names>TP</given-names></name><name><surname>Raaben</surname><given-names>M</given-names></name><name><surname>Grinwis</surname><given-names>GC</given-names></name><name><surname>Coenjaerts</surname><given-names>FE</given-names></name><name><surname>Ressing</surname><given-names>ME</given-names></name><name><surname>Rottier</surname><given-names>PJ</given-names></name><name><surname>de Haan</surname><given-names>CA</given-names></name><name><surname>Meyaard</surname><given-names>L</given-names></name></person-group>
<year>2012</year>
<article-title>CD200 receptor controls sex-specific TLR7 responses to viral infection</article-title>. <source>PLoS Pathog.</source>
<volume>8</volume>:<fpage>e1002710</fpage>. <pub-id pub-id-type="doi">10.1371/journal.ppat.1002710</pub-id><pub-id pub-id-type="pmid">22615569</pub-id></mixed-citation></ref><ref id="B43"><label>43.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Strassheim</surname><given-names>S</given-names></name><name><surname>Stik</surname><given-names>G</given-names></name><name><surname>Rasschaert</surname><given-names>D</given-names></name><name><surname>Laurent</surname><given-names>S</given-names></name></person-group>
<year>2012</year>
<article-title>mdv1-miR-M7-5p, located in the newly identified first intron of the latency-associated transcript of Marek&#x02019;s disease virus, targets the immediate-early genes ICP4 and ICP27</article-title>. <source>J. Gen. Virol.</source>
<volume>93</volume>:<fpage>1731</fpage>&#x02013;<lpage>1742</lpage>. <pub-id pub-id-type="doi">10.1099/vir.0.043109-0</pub-id><pub-id pub-id-type="pmid">22513387</pub-id></mixed-citation></ref><ref id="B44"><label>44.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Engel</surname><given-names>AT</given-names></name><name><surname>Selvaraj</surname><given-names>RK</given-names></name><name><surname>Kamil</surname><given-names>JP</given-names></name><name><surname>Osterrieder</surname><given-names>N</given-names></name><name><surname>Kaufer</surname><given-names>BB</given-names></name></person-group>
<year>2012</year>
<article-title>Marek&#x02019;s disease viral interleukin-8 promotes lymphoma formation through targeted recruitment of B cells and CD4+ CD25+ T cells</article-title>. <source>J. Virol.</source>
<volume>86</volume>:<fpage>8536</fpage>&#x02013;<lpage>8545</lpage>. <pub-id pub-id-type="doi">10.1128/JVI.00556-12</pub-id><pub-id pub-id-type="pmid">22647701</pub-id></mixed-citation></ref><ref id="B45"><label>45.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Parcells</surname><given-names>MS</given-names></name><name><surname>Lin</surname><given-names>SF</given-names></name><name><surname>Dienglewicz</surname><given-names>RL</given-names></name><name><surname>Majerciak</surname><given-names>V</given-names></name><name><surname>Robinson</surname><given-names>DR</given-names></name><name><surname>Chen</surname><given-names>HC</given-names></name><name><surname>Wu</surname><given-names>Z</given-names></name><name><surname>Dubyak</surname><given-names>GR</given-names></name><name><surname>Brunovskis</surname><given-names>P</given-names></name><name><surname>Hunt</surname><given-names>HD</given-names></name><name><surname>Lee</surname><given-names>LF</given-names></name><name><surname>Kung</surname><given-names>HJ</given-names></name></person-group>
<year>2001</year>
<article-title>Marek&#x02019;s disease virus (MDV) encodes an interleukin-8 homolog (vIL-8): characterization of the vIL-8 protein and a vIL-8 deletion mutant MDV</article-title>. <source>J. Virol.</source>
<volume>75</volume>:<fpage>5159</fpage>&#x02013;<lpage>5173</lpage>. <pub-id pub-id-type="doi">10.1128/JVI.75.11.5159-5173.2001</pub-id><pub-id pub-id-type="pmid">11333897</pub-id></mixed-citation></ref><ref id="B46"><label>46.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bolisetty</surname><given-names>MT</given-names></name><name><surname>Dy</surname><given-names>G</given-names></name><name><surname>Tam</surname><given-names>W</given-names></name><name><surname>Beemon</surname><given-names>KL</given-names></name></person-group>
<year>2009</year>
<article-title>Reticuloendotheliosis virus strain T induces miR-155, which targets JARID2 and promotes cell survival</article-title>. <source>J. Virol.</source>
<volume>83</volume>:<fpage>12009</fpage>&#x02013;<lpage>12017</lpage><pub-id pub-id-type="pmid">19759154</pub-id></mixed-citation></ref><ref id="B47"><label>47.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jim&#x000e9;nez-Velasco</surname><given-names>A</given-names></name><name><surname>Rom&#x000e1;n-G&#x000f3;mez</surname><given-names>J</given-names></name><name><surname>Agirre</surname><given-names>X</given-names></name><name><surname>Barrios</surname><given-names>M</given-names></name><name><surname>Navarro</surname><given-names>G</given-names></name><name><surname>V&#x000e1;zquez</surname><given-names>I</given-names></name><name><surname>Pr&#x000f3;sper</surname><given-names>F</given-names></name><name><surname>Torres</surname><given-names>A</given-names></name><name><surname>Heiniger</surname><given-names>A</given-names></name></person-group>
<year>2005</year>
<article-title>Downregulation of the large tumor suppressor 2 (LATS2/KPM) gene is associated with poor prognosis in acute lymphoblastic leukemia</article-title>. <source>Leukemia</source>
<volume>19</volume>:<fpage>2347</fpage>&#x02013;<lpage>2350</lpage>. <pub-id pub-id-type="doi">10.1038/sj.leu.2403974</pub-id><pub-id pub-id-type="pmid">16208412</pub-id></mixed-citation></ref><ref id="B48"><label>48.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Senftleben</surname><given-names>U</given-names></name><name><surname>Cao</surname><given-names>Y</given-names></name><name><surname>Xiao</surname><given-names>G</given-names></name><name><surname>Greten</surname><given-names>FR</given-names></name><name><surname>Kr&#x000e4;hn</surname><given-names>G</given-names></name><name><surname>Bonizzi</surname><given-names>G</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Hu</surname><given-names>Y</given-names></name><name><surname>Fong</surname><given-names>A</given-names></name><name><surname>Sun</surname><given-names>SC</given-names></name><name><surname>Karin</surname><given-names>M</given-names></name></person-group>
<year>2001</year>
<article-title>Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway</article-title>. <source>Science</source>
<volume>293</volume>:<fpage>1495</fpage>&#x02013;<lpage>1499</lpage>. <pub-id pub-id-type="doi">10.1126/science.1062677</pub-id><pub-id pub-id-type="pmid">11520989</pub-id></mixed-citation></ref><ref id="B49"><label>49.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Claudio</surname><given-names>E</given-names></name><name><surname>Brown</surname><given-names>K</given-names></name><name><surname>Park</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Siebenlist</surname><given-names>U</given-names></name></person-group>
<year>2002</year>
<article-title>BAFF-induced NEMO-independent processing of NF-kappa B2 in maturing B cells</article-title>. <source>Nat. Immunol.</source>
<volume>3</volume>:<fpage>958</fpage>&#x02013;<lpage>965</lpage>. <pub-id pub-id-type="doi">10.1038/ni842</pub-id><pub-id pub-id-type="pmid">12352969</pub-id></mixed-citation></ref><ref id="B50"><label>50.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yin</surname><given-names>L</given-names></name><name><surname>Wu</surname><given-names>L</given-names></name><name><surname>Wesche</surname><given-names>H</given-names></name><name><surname>Arthur</surname><given-names>CD</given-names></name><name><surname>White</surname><given-names>JM</given-names></name><name><surname>Goeddel</surname><given-names>DV</given-names></name><name><surname>Schreiber</surname><given-names>RD</given-names></name></person-group>
<year>2001</year>
<article-title>Defective lymphotoxin-beta receptor-induced NF-kappaB transcriptional activity in NIK-deficient mice</article-title>. <source>Science</source>
<volume>291</volume>:<fpage>2162</fpage>&#x02013;<lpage>2165</lpage>. <pub-id pub-id-type="doi">10.1126/science.1058453</pub-id><pub-id pub-id-type="pmid">11251123</pub-id></mixed-citation></ref><ref id="B51"><label>51.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rowe</surname><given-names>AM</given-names></name><name><surname>Murray</surname><given-names>SE</given-names></name><name><surname>Rau&#x000e9;</surname><given-names>HP</given-names></name><name><surname>Koguchi</surname><given-names>Y</given-names></name><name><surname>Slifka</surname><given-names>MK</given-names></name><name><surname>Parker</surname><given-names>DC</given-names></name></person-group>
<year>2013</year>
<article-title>A cell-intrinsic requirement for NF- &#x003ba;B-inducing kinase in CD4 and CD8 T cell memory</article-title>. <source>J. Immunol.</source>
<volume>191</volume>:<fpage>3663</fpage>&#x02013;<lpage>3672</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.1301328</pub-id><pub-id pub-id-type="pmid">24006459</pub-id></mixed-citation></ref><ref id="B52"><label>52.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Umbach</surname><given-names>JL</given-names></name><name><surname>Cullen</surname><given-names>BR</given-names></name></person-group>
<year>2010</year>
<article-title>In-depth analysis of Kaposi&#x02019;s sarcoma-associated herpesvirus microRNA expression provides insights into the mammalian microRNA-processing machinery</article-title>. <source>J. Virol.</source>
<volume>84</volume>:<fpage>695</fpage>&#x02013;<lpage>703</lpage>. <pub-id pub-id-type="doi">10.1128/JVI.02013-09</pub-id><pub-id pub-id-type="pmid">19889781</pub-id></mixed-citation></ref><ref id="B53"><label>53.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Langmead</surname><given-names>B</given-names></name><name><surname>Trapnell</surname><given-names>C</given-names></name><name><surname>Pop</surname><given-names>M</given-names></name><name><surname>Salzberg</surname><given-names>SL</given-names></name></person-group>
<year>2009</year>
<article-title>Ultrafast and memory-efficient alignment of short DNA sequences to the human genome</article-title>. <source>Genome Biol.</source>
<volume>10</volume>:<fpage>R25</fpage>. <pub-id pub-id-type="doi">10.1186/gb-2009-10-3-r25</pub-id><pub-id pub-id-type="pmid">19261174</pub-id></mixed-citation></ref><ref id="B54"><label>54.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Robinson</surname><given-names>JT</given-names></name><name><surname>Thorvaldsd&#x000f3;ttir</surname><given-names>H</given-names></name><name><surname>Winckler</surname><given-names>W</given-names></name><name><surname>Guttman</surname><given-names>M</given-names></name><name><surname>Lander</surname><given-names>ES</given-names></name><name><surname>Getz</surname><given-names>G</given-names></name><name><surname>Mesirov</surname><given-names>JP</given-names></name></person-group>
<year>2011</year>
<article-title>Integrative genomics viewer</article-title>. <source>Nat. Biotechnol.</source>
<volume>29</volume>:<fpage>24</fpage>&#x02013;<lpage>26</lpage>. <pub-id pub-id-type="doi">10.1038/nbt.1754</pub-id><pub-id pub-id-type="pmid">21221095</pub-id></mixed-citation></ref><ref id="B55"><label>55.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Thorvaldsd&#x000f3;ttir</surname><given-names>H</given-names></name><name><surname>Robinson</surname><given-names>JT</given-names></name><name><surname>Mesirov</surname><given-names>JP</given-names></name></person-group>
<year>2013</year>
<article-title>Integrative Genomics viewer (IGV): high-performance genomics data visualization and exploration</article-title>. <source>Brief. Bioinform.</source>
<volume>14</volume>:<fpage>178</fpage>&#x02013;<lpage>192</lpage>. <pub-id pub-id-type="doi">10.1093/bib/bbs017</pub-id><pub-id pub-id-type="pmid">22517427</pub-id></mixed-citation></ref><ref id="B56"><label>56.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Dull</surname><given-names>T</given-names></name><name><surname>Zufferey</surname><given-names>R</given-names></name><name><surname>Kelly</surname><given-names>M</given-names></name><name><surname>Mandel</surname><given-names>RJ</given-names></name><name><surname>Nguyen</surname><given-names>M</given-names></name><name><surname>Trono</surname><given-names>D</given-names></name><name><surname>Naldini</surname><given-names>L</given-names></name></person-group>
<year>1998</year>
<article-title>A third-generation lentivirus vector with a conditional packaging system</article-title>. <source>J. Virol.</source>
<volume>72</volume>:<fpage>8463</fpage>&#x02013;<lpage>8471</lpage><pub-id pub-id-type="pmid">9765382</pub-id></mixed-citation></ref><ref id="B57"><label>57.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Jima</surname><given-names>DD</given-names></name><name><surname>Jacobs</surname><given-names>C</given-names></name><name><surname>Fischer</surname><given-names>R</given-names></name><name><surname>Gottwein</surname><given-names>E</given-names></name><name><surname>Huang</surname><given-names>G</given-names></name><name><surname>Lugar</surname><given-names>PL</given-names></name><name><surname>Lagoo</surname><given-names>AS</given-names></name><name><surname>Rizzieri</surname><given-names>DA</given-names></name><name><surname>Friedman</surname><given-names>DR</given-names></name><name><surname>Weinberg</surname><given-names>JB</given-names></name><name><surname>Lipsky</surname><given-names>PE</given-names></name><name><surname>Dave</surname><given-names>SS</given-names></name></person-group>
<year>2009</year>
<article-title>Patterns of microRNA expression characterize stages of human B-cell differentiation</article-title>. <source>Blood</source>
<volume>113</volume>:<fpage>4586</fpage>&#x02013;<lpage>4594</lpage>. <pub-id pub-id-type="doi">10.1182/blood-2008-09-178186</pub-id><pub-id pub-id-type="pmid">19202128</pub-id></mixed-citation></ref><ref id="B58"><label>58.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gottwein</surname><given-names>E</given-names></name><name><surname>Cullen</surname><given-names>BR</given-names></name></person-group>
<year>2010</year>
<article-title>A human herpesvirus microRNA inhibits p21 expression and attenuates p21-mediated cell cycle arrest</article-title>. <source>J. Virol.</source>
<volume>84</volume>:<fpage>5229</fpage>&#x02013;<lpage>5237</lpage>. <pub-id pub-id-type="doi">10.1128/JVI.00202-10</pub-id><pub-id pub-id-type="pmid">20219912</pub-id></mixed-citation></ref></ref-list></back></article>